
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            BRCA1 Mutation Status and Follicular Fluid Exposure Alters NFκB Signaling and ISGylation in Human Fallopian Tube Epithelial Cells - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B377D926468D33C377D0036DA591C.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="neoplasia">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6030391/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Neoplasia (New York, N.Y.)">
<meta name="citation_title" content="BRCA1 Mutation Status and Follicular Fluid Exposure Alters NFκB Signaling and ISGylation in Human Fallopian Tube Epithelial Cells">
<meta name="citation_author" content="Julia Hollingsworth">
<meta name="citation_author_institution" content="The Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON">
<meta name="citation_author_institution" content="Institute of Medical Sciences, University of Toronto, Toronto, ON">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON">
<meta name="citation_author" content="Angela Lau">
<meta name="citation_author_institution" content="The Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON">
<meta name="citation_author_institution" content="Department of Physiology, University of Toronto, Toronto, ON">
<meta name="citation_author" content="Alicia Tone">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON">
<meta name="citation_author_institution" content="Division of Gynecologic Oncology, Princess Margaret Cancer Centre, Toronto, ON">
<meta name="citation_author" content="Alexandra Kollara">
<meta name="citation_author_institution" content="The Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON">
<meta name="citation_author" content="Lisa Allen">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON">
<meta name="citation_author" content="Terence J Colgan">
<meta name="citation_author_institution" content="The Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON">
<meta name="citation_author_institution" content="Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON">
<meta name="citation_author_institution" content="Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON">
<meta name="citation_author" content="Valerie Dube">
<meta name="citation_author_institution" content="Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON">
<meta name="citation_author_institution" content="Department of Pathology, Women’s College Hospital, Toronto, ON">
<meta name="citation_author" content="Barry Rosen">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON">
<meta name="citation_author_institution" content="Division of Gynecologic Oncology, Princess Margaret Cancer Centre, Toronto, ON">
<meta name="citation_author" content="K Joan Murphy">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON">
<meta name="citation_author_institution" content="Division of Gynecologic Oncology, Princess Margaret Cancer Centre, Toronto, ON">
<meta name="citation_author" content="Ellen M Greenblatt">
<meta name="citation_author_institution" content="The Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON">
<meta name="citation_author" content="Tomer Feigenberg">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON">
<meta name="citation_author_institution" content="Division of Gynecologic Oncology, Princess Margaret Cancer Centre, Toronto, ON">
<meta name="citation_author" content="Carl Virtanen">
<meta name="citation_author_institution" content="Princess Margaret Genomics Centre, Toronto, ON">
<meta name="citation_author" content="Theodore J Brown">
<meta name="citation_author_institution" content="The Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON">
<meta name="citation_author_institution" content="Institute of Medical Sciences, University of Toronto, Toronto, ON">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON">
<meta name="citation_author_institution" content="Department of Physiology, University of Toronto, Toronto, ON">
<meta name="citation_publication_date" content="2018 May 28">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="7">
<meta name="citation_firstpage" content="697">
<meta name="citation_doi" content="10.1016/j.neo.2018.05.005">
<meta name="citation_pmid" content="29852322">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6030391/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6030391/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6030391/pdf/main.pdf">
<meta name="description" content="Germline BRCA1 or BRCA2 mutations (mtBRCA1 and mtBRCA2) increase risk for high-grade serous ovarian cancer (HGSOC), the most commonly diagnosed epithelial ovarian cancer histotype. Other identified risk factors for this cancer, which originates ...">
<meta name="og:title" content="BRCA1 Mutation Status and Follicular Fluid Exposure Alters NFκB Signaling and ISGylation in Human Fallopian Tube Epithelial Cells">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Germline BRCA1 or BRCA2 mutations (mtBRCA1 and mtBRCA2) increase risk for high-grade serous ovarian cancer (HGSOC), the most commonly diagnosed epithelial ovarian cancer histotype. Other identified risk factors for this cancer, which originates ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6030391/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="6030391">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1016/j.neo.2018.05.005"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/main.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC6030391%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/6030391/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/6030391/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC6030391/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-neoplasia.gif" alt="Neoplasia (New York, N.Y.) logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Neoplasia (New York, N.Y.)" title="Link to Neoplasia (New York, N.Y.)" shape="default" href="http://www.neoplasia.com" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Neoplasia</button></div>. 2018 May 28;20(7):697–709. doi: <a href="https://doi.org/10.1016/j.neo.2018.05.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1016/j.neo.2018.05.005</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Neoplasia%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Neoplasia%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Neoplasia%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Neoplasia%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>
<em>BRCA1</em> Mutation Status and Follicular Fluid Exposure Alters NFκB Signaling and ISGylation in Human Fallopian Tube Epithelial Cells<sup><a href="#d31e920" class="usa-link">1</a></sup><sup><a href="#d31e934" class="usa-link">2</a></sup>
</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hollingsworth%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Julia Hollingsworth</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Julia Hollingsworth</span></h3>
<div class="p">
<sup>*</sup>The Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON</div>
<div class="p">
<sup>†</sup>Institute of Medical Sciences, University of Toronto, Toronto, ON</div>
<div class="p">
<sup>‡</sup>Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hollingsworth%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Julia Hollingsworth</span></a>
</div>
</div>
<sup>*,</sup><sup>†,</sup><sup>‡,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lau%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Angela Lau</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Angela Lau</span></h3>
<div class="p">
<sup>*</sup>The Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON</div>
<div class="p">
<sup>‡</sup>Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON</div>
<div class="p">
<sup>§</sup>Department of Physiology, University of Toronto, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lau%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Angela Lau</span></a>
</div>
</div>
<sup>*,</sup><sup>‡,</sup><sup>§,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tone%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Alicia Tone</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Alicia Tone</span></h3>
<div class="p">
<sup>‡</sup>Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON</div>
<div class="p">
<sup>#</sup>Division of Gynecologic Oncology, Princess Margaret Cancer Centre, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tone%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alicia Tone</span></a>
</div>
</div>
<sup>‡,</sup><sup>#,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kollara%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Alexandra Kollara</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Alexandra Kollara</span></h3>
<div class="p">
<sup>*</sup>The Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON</div>
<div class="p">
<sup>‡</sup>Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kollara%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexandra Kollara</span></a>
</div>
</div>
<sup>*,</sup><sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Allen%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Lisa Allen</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Lisa Allen</span></h3>
<div class="p">
<sup>‡</sup>Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Allen%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lisa Allen</span></a>
</div>
</div>
<sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Colgan%20TJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Terence J Colgan</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Terence J Colgan</span></h3>
<div class="p">
<sup>*</sup>The Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON</div>
<div class="p">
<sup>¶</sup>Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON</div>
<div class="p">
<sup>**</sup>Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Colgan%20TJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Terence J Colgan</span></a>
</div>
</div>
<sup>*,</sup><sup>¶,</sup><sup>**</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dube%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Valerie Dube</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Valerie Dube</span></h3>
<div class="p">
<sup>¶</sup>Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON</div>
<div class="p">
<sup>††</sup>Department of Pathology, Women’s College Hospital, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dube%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Valerie Dube</span></a>
</div>
</div>
<sup>¶,</sup><sup>††,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rosen%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Barry Rosen</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Barry Rosen</span></h3>
<div class="p">
<sup>‡</sup>Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON</div>
<div class="p">
<sup>#</sup>Division of Gynecologic Oncology, Princess Margaret Cancer Centre, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rosen%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Barry Rosen</span></a>
</div>
</div>
<sup>‡,</sup><sup>#,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Murphy%20KJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">K Joan Murphy</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">K Joan Murphy</span></h3>
<div class="p">
<sup>‡</sup>Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON</div>
<div class="p">
<sup>#</sup>Division of Gynecologic Oncology, Princess Margaret Cancer Centre, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Murphy%20KJ%22%5BAuthor%5D" class="usa-link"><span class="name western">K Joan Murphy</span></a>
</div>
</div>
<sup>‡,</sup><sup>#,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Greenblatt%20EM%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Ellen M Greenblatt</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Ellen M Greenblatt</span></h3>
<div class="p">
<sup>*</sup>The Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON</div>
<div class="p">
<sup>‡</sup>Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Greenblatt%20EM%22%5BAuthor%5D" class="usa-link"><span class="name western">Ellen M Greenblatt</span></a>
</div>
</div>
<sup>*,</sup><sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Feigenberg%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Tomer Feigenberg</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Tomer Feigenberg</span></h3>
<div class="p">
<sup>‡</sup>Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON</div>
<div class="p">
<sup>#</sup>Division of Gynecologic Oncology, Princess Margaret Cancer Centre, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Feigenberg%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tomer Feigenberg</span></a>
</div>
</div>
<sup>‡,</sup><sup>#,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Virtanen%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Carl Virtanen</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Carl Virtanen</span></h3>
<div class="p">
<sup>‡‡</sup>Princess Margaret Genomics Centre, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Virtanen%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Carl Virtanen</span></a>
</div>
</div>
<sup>‡‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Brown%20TJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Theodore J Brown</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Theodore J Brown</span></h3>
<div class="p">
<sup>*</sup>The Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON</div>
<div class="p">
<sup>†</sup>Institute of Medical Sciences, University of Toronto, Toronto, ON</div>
<div class="p">
<sup>‡</sup>Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON</div>
<div class="p">
<sup>§</sup>Department of Physiology, University of Toronto, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Brown%20TJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Theodore J Brown</span></a>
</div>
</div>
<sup>*,</sup><sup>†,</sup><sup>‡,</sup><sup>§,</sup><sup>⁎</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af0005">
<sup>*</sup>The Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON</div>
<div id="af0010">
<sup>†</sup>Institute of Medical Sciences, University of Toronto, Toronto, ON</div>
<div id="af0015">
<sup>‡</sup>Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON</div>
<div id="af0020">
<sup>§</sup>Department of Physiology, University of Toronto, Toronto, ON</div>
<div id="af0025">
<sup>¶</sup>Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON</div>
<div id="af0030">
<sup>#</sup>Division of Gynecologic Oncology, Princess Margaret Cancer Centre, Toronto, ON</div>
<div id="af0035">
<sup>**</sup>Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON</div>
<div id="af0040">
<sup>††</sup>Department of Pathology, Women’s College Hospital, Toronto, ON</div>
<div id="af0045">
<sup>‡‡</sup>Princess Margaret Genomics Centre, Toronto, ON</div>
<div class="author-notes p">
<div class="fn" id="cr0005">
<sup>⁎</sup><p class="display-inline">Address all correspondence to: Theodore J. Brown, PhD, Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, 60 Murray Street, Box 42, Toronto, ON M5T 3L9. <span>brown@lunenfeld.ca</span></p>
</div>
<div class="fn" id="fn0005">
<sup>3</sup><p class="display-inline" id="np0020">Contributed equally to the work.</p>
</div>
<div class="fn" id="fn0010">
<sup>4</sup><p class="display-inline" id="np0025">Present affiliation: Trillium Health Partners; Mississauga, ON, Canada.</p>
</div>
<div class="fn" id="fn0015">
<sup>5</sup><p class="display-inline" id="np0030">Present affiliation: Beaumont Health System; Royal Oak, MI, USA.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2018 Apr 13; Revised 2018 May 7; Accepted 2018 May 11; Collection date 2018 Jul.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2018 The Authors</div>
<p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC6030391  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29852322/" class="usa-link">29852322</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="ab0005"><h2>Abstract</h2>
<p>Germline <em>BRCA1</em> or <em>BRCA2</em> mutations (mt<em>BRCA1</em> and mt<em>BRCA2</em>) increase risk for high-grade serous ovarian cancer (HGSOC), the most commonly diagnosed epithelial ovarian cancer histotype. Other identified risk factors for this cancer, which originates primarily in the distal fallopian tube epithelium (FTE), implicate ovulation, during which the FTE cells become transiently exposed to follicular fluid (FF). To test whether mt<em>BRCA1</em> or mt<em>BRCA2</em> nonmalignant FTE cells respond differently to periovulatory FF exposure than control patient FTE cells, gene expression profiles from primary FTE cultures derived from <em>BRCA1</em> or <em>BRCA2</em> mutation carriers or control patients were compared at baseline, 24 hours after FF exposure, and 24 hours after FF replacement with culture medium. Hierarchical clustering revealed both FF exposure and <em>BRCA</em> mutation status affect gene expression, with <em>BRCA1</em> mutation having the greatest impact. Gene set enrichment analysis revealed increased NFκB and EGFR signaling at baseline in mt<em>BRCA1</em> samples, with increased interferon target gene expression, including members of the ISGylation pathway, observed after recovery from FF exposure. Gene set enrichment analysis did not identify altered pathway signaling in mt<em>BRCA2</em> samples. An inverse relationship between EGFR signaling and ISGylation with BRCA1 protein levels was verified in an immortalized FTE cell line, OE-E6/E7, stably transfected with BRCA1 cDNA. Suppression of ISG15 and ISGylated protein levels by increased BRCA1 expression was found to be mediated by decreased NFκB signaling. These studies indicate that increased NFκB signaling associated with decreased BRCA1 expression results in increased ISG15 and protein ISGylation following FF exposure, which may be involved in predisposition to HGSOC.</p>
<section id="ks0005" class="kwd-group"><p><strong>Abbreviations:</strong> ACHP, 2-amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-(4-piperidinyl)-3-pyridinecarbonitrile; BRCA1, breast cancer 1, early onset; BRCA2, breast cancer 2, early onset; EGFR, epidermal growth factor receptor; FBS, fetal bovine serum; FDR, false discovery rate; FF, follicular fluid; FTE, fallopian tube epithelium; GO, Gene Ontology; GSEA, gene set enrichment analysis; HGSOC, high-grade serous ovarian cancer; mt<em>BRCA1</em>, BRCA1 mutation; mt<em>BRCA2</em>, BRCA2 mutation</p></section></section><section id="s0005"><h2 class="pmc_sec_title">Introduction</h2>
<p id="p0005">Ovarian cancers of epithelial derivation are composed of multiple histotypes that differ in commonly mutated genes, clinical course, and presumed cell of origin. Among these histotypes, high-grade serous ovarian cancer (HGSOC), which originates primarily in the fimbrial fallopian tube epithelium (FTE), accounts for the majority of deaths <a href="#bb0005" class="usa-link" aria-describedby="bb0005">[1]</a>. The most significant risk factor for HGSOC is a family history of breast or ovarian cancer, with heritable mutations in <em>breast cancer 1, early onset</em> (<em>BRCA1</em>) or <em>breast cancer 2, early onset</em> (<em>BRCA2</em>) genes conferring most of this familial risk. Germline <em>BRCA1</em> mutation (mt<em>BRCA1</em>) carriers have a lifetime HGSOC risk of up to 60% compared to 1.4% to 1.7% for the general female population, whereas germline <em>BRCA2</em> mutation (mt<em>BRCA2</em>) carriers have a lifetime risk of up to 23% <a href="#bb0010" class="usa-link" aria-describedby="bb0010">[2]</a>, <a href="#bb0015" class="usa-link" aria-describedby="bb0015">[3]</a>, <a href="#bb0020" class="usa-link" aria-describedby="bb0020">[4]</a>. mt<em>BRCA1</em> carriers also tend to be diagnosed at an earlier age than either mt<em>BRCA2</em> carriers or sporadic cases <a href="#bb0025" class="usa-link" aria-describedby="bb0025">[5]</a>, suggesting acceleration of the carcinogenic process by BRCA1 insufficiency.</p>
<p id="p0010">Additional risk factors for HGSOC are consistent with a promoting role for an increased number of lifetime ovulatory events. The use of oral contraceptives, increased parity, lactation, early menopause, and potentially late menarche reduce risk in the general population <a href="#bb0030" class="usa-link" aria-describedby="bb0030">[6]</a>, <a href="#bb0035" class="usa-link" aria-describedby="bb0035">[7]</a> and in mt<em>BRCA1</em> and mt<em>BRCA2</em> carriers <a href="#bb0040" class="usa-link" aria-describedby="bb0040">[8]</a>, <a href="#bb0045" class="usa-link" aria-describedby="bb0045">[9]</a>. Ovulation is a recurring event involving a cascade of inflammatory signaling pathways triggered by the LH surge that culminates in the release of the cumulus-oocyte complex and follicular fluid (FF) into the fimbria of the fallopian tube. As a result of the dynamic intrafollicular signaling leading up to ovulation, this periovulatory FF contains cytokines, chemokines, free radicals, and steroid hormones <a href="#bb0050" class="usa-link" aria-describedby="bb0050">[10]</a>. Repetitive exposure of the FTE to these FF factors could promote carcinogenesis, perhaps through increased DNA adduct formation and gene mutation to drive development of HGSOC precursors in the distal FTE <a href="#bb0055" class="usa-link" aria-describedby="bb0055">[11]</a>.</p>
<p id="p0015">We previously reported that gene expression profiles from nonmalignant FTE from mt<em>BRCA1</em> carriers obtained during the postovulatory luteal phase more closely resembled HGSOC than FTE either from control patients or from mt<em>BRCA1</em> carriers obtained during the follicular phase <a href="#bb0060" class="usa-link" aria-describedby="bb0060">[12]</a>. Further characterization of the molecular differences indicated an increased expression of proinflammatory genes in luteal phase FTE from mt<em>BRCA1</em> carriers <a href="#bb0065" class="usa-link" aria-describedby="bb0065">[13]</a>. This surprising finding suggested that FTE from mt<em>BRCA1</em> carriers might respond differently to ovulation or to the luteal phase milieu.</p>
<p id="p0020">The primary objective of the current study was to determine whether the response to FF exposure of nonmalignant FTE cells derived from mt<em>BRCA1</em> or mt<em>BRCA2</em> carriers differs from that of cells derived from control patients. Our findings demonstrate increased inflammatory and epidermal growth factor receptor (EGFR) pathway signaling in FTE from <em>BRCA1</em> mutation carriers. We also provide evidence of increased ISGylation, a posttranslational protein modification, in <em>BRCA1</em>-deficient cells following exposure to periovulatory FF, raising the possibility that this pathway may contribute to predisposition to HGSOC.</p></section><section id="s0010"><h2 class="pmc_sec_title">Materials and Methods</h2>
<section id="s0015"><h3 class="pmc_sec_title">Patient Samples</h3>
<p id="p0025">Fallopian tube surgical specimens were obtained from 24 women with either known <em>BRCA1</em> mutations (<em>n</em>=8) or known <em>BRCA2</em> mutations (<em>n</em>=8), or with no personal or known family history of breast or ovarian cancer (<em>n</em>=8). All mt<em>BRCA1</em> and mt<em>BRCA2</em> carriers underwent risk-reducing salpingo-oophorectomy, whereas control patients underwent surgery for benign conditions (<a href="#t0005" class="usa-link">Table 1</a>). The study was approved by Mount Sinai Hospital and Women’s College Hospital Research Ethics Boards, and all patients provided informed consent prior to tissue donation.</p>
<section class="tw xbox font-sm" id="t0005"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Age and <em>BRCA1</em> and <em>BRCA2</em> Mutations for Patients Contributing Surgical Samples for FTE Derivation<a href="#tf0005" class="usa-link"><sup>a</sup></a></p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">Patient ID</th>
<th colspan="1" rowspan="1">Age (Years)<sup>⁎</sup>
</th>
<th colspan="1" rowspan="1">Indication for Surgery</th>
<th colspan="1" rowspan="1">Mutation Status</th>
</tr></thead>
<tbody>
<tr><td colspan="4" rowspan="1"><strong><em>BRCA1</em></strong></td></tr>
<tr>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">50</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">c.5266dupC</td>
</tr>
<tr>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">38</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">5083del19</td>
</tr>
<tr>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">49</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">c.4484G&gt;T</td>
</tr>
<tr>
<td colspan="1" rowspan="1">4</td>
<td colspan="1" rowspan="1">38</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">3875delGTCT</td>
</tr>
<tr>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">38</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">c.1994delA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">41</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">c.4484G&gt;T</td>
</tr>
<tr>
<td colspan="1" rowspan="1">7</td>
<td colspan="1" rowspan="1">39</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">5382insC</td>
</tr>
<tr>
<td colspan="1" rowspan="1">8</td>
<td colspan="1" rowspan="1">41</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">185delAG</td>
</tr>
<tr><td colspan="4" rowspan="1">  </td></tr>
<tr><td colspan="4" rowspan="1"><strong><em>BRCA2</em></strong></td></tr>
<tr>
<td colspan="1" rowspan="1">9</td>
<td colspan="1" rowspan="1">37</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">3331G&gt;T</td>
</tr>
<tr>
<td colspan="1" rowspan="1">10</td>
<td colspan="1" rowspan="1">44</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">6884C&gt;G</td>
</tr>
<tr>
<td colspan="1" rowspan="1">11</td>
<td colspan="1" rowspan="1">33</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">5972C&gt;T</td>
</tr>
<tr>
<td colspan="1" rowspan="1">12</td>
<td colspan="1" rowspan="1">48</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">c.9435_9436delGT</td>
</tr>
<tr>
<td colspan="1" rowspan="1">13</td>
<td colspan="1" rowspan="1">51</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">c.517-2A&gt;G</td>
</tr>
<tr>
<td colspan="1" rowspan="1">14</td>
<td colspan="1" rowspan="1">54</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">3036delACAA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">15</td>
<td colspan="1" rowspan="1">41</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">c.5909C&gt;A</td>
</tr>
<tr>
<td colspan="1" rowspan="1">16</td>
<td colspan="1" rowspan="1">42</td>
<td colspan="1" rowspan="1">RRSO</td>
<td colspan="1" rowspan="1">9894delT</td>
</tr>
<tr><td colspan="4" rowspan="1">  </td></tr>
<tr><td colspan="4" rowspan="1"><strong><em>Control</em></strong></td></tr>
<tr>
<td colspan="1" rowspan="1">17</td>
<td colspan="1" rowspan="1">56</td>
<td colspan="1" rowspan="1">Uterine fibroids</td>
<td colspan="1" rowspan="1">N/D</td>
</tr>
<tr>
<td colspan="1" rowspan="1">18</td>
<td colspan="1" rowspan="1">52</td>
<td colspan="1" rowspan="1">Uterine fibroids</td>
<td colspan="1" rowspan="1">N/D</td>
</tr>
<tr>
<td colspan="1" rowspan="1">19</td>
<td colspan="1" rowspan="1">54</td>
<td colspan="1" rowspan="1">Endometrial hyperplasia</td>
<td colspan="1" rowspan="1">N/D</td>
</tr>
<tr>
<td colspan="1" rowspan="1">20</td>
<td colspan="1" rowspan="1">50</td>
<td colspan="1" rowspan="1">Dermatoid cyst</td>
<td colspan="1" rowspan="1">N/D</td>
</tr>
<tr>
<td colspan="1" rowspan="1">21</td>
<td colspan="1" rowspan="1">33</td>
<td colspan="1" rowspan="1">Uterine fibroids</td>
<td colspan="1" rowspan="1">N/D</td>
</tr>
<tr>
<td colspan="1" rowspan="1">22</td>
<td colspan="1" rowspan="1">52</td>
<td colspan="1" rowspan="1">Uterine fibroids</td>
<td colspan="1" rowspan="1">N/D</td>
</tr>
<tr>
<td colspan="1" rowspan="1">23</td>
<td colspan="1" rowspan="1">48</td>
<td colspan="1" rowspan="1">Uterine fibroids</td>
<td colspan="1" rowspan="1">N/D</td>
</tr>
<tr>
<td colspan="1" rowspan="1">24</td>
<td colspan="1" rowspan="1">47</td>
<td colspan="1" rowspan="1">Uterine fibroids</td>
<td colspan="1" rowspan="1">N/D</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn4"><p><em>RRSO</em>, risk-reducing salpingo-oophorectomy; <em>N/D</em>, not determined.</p></div>
<div class="fn" id="tf0005">
<sup>a</sup><p class="display-inline" id="np0005">The average age (±SEM) for <em>BRCA1</em> mutation carriers, <em>BRCA2</em> mutation carriers, and control patients was 41.7 (±1.7), 43.7 (±2.5), and 49.0 (±2.5) years, respectively [<em>F</em><sub>(2, 21)</sub>=2.698, <em>P</em>=.091].</p>
</div>
</div></section></section><section id="s0020"><h3 class="pmc_sec_title">Primary FTE Culture</h3>
<p id="p0030">Tissue fragments were washed, minced, and incubated for 48 hours in MEM (Invitrogen, Burlington, Canada) containing 1.4 mg/ml Pronase and 0.1 mg/ml DNase I (Roche Diagnostics, Laval, Canada) at 4°C. Enzymes were inactivated by addition of fetal bovine serum (FBS) to 10% (v/v). Dissociated cells were collected; resuspended in DMEM supplemented with 10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, and 0.625μg amphotericin (Invitrogen); and transferred to a positively charged culture plate for 3 to 4 hours. Nonadherent cells were collected and seeded onto collagen type IV–coated Transwell inserts at &gt;75% confluency, as previously described <a href="#bb0070" class="usa-link" aria-describedby="bb0070">[14]</a>. All cultures were maintained with culture medium in both chambers. Medium was replaced every 48 hours until cultures were confluent. Cultures consisted of 49.6%±2.9% (mean±SEM) secretory epithelial cells, 38.0%±2.0% ciliated epithelial cells, and 11.7%±1.6% stromal cells, as determined by immunostaining for Pax8 (ProteinTech, Rosemont, IL), FoxJ1 (Abcam, Cambridge, MA), and vimentin (Dako, Mississauga, Canada), respectively (<em>n</em>=4).</p></section><section id="s0025"><h3 class="pmc_sec_title">OE-E6/E7 Cell Culture</h3>
<p id="p0035">OE-E6/E7 cells <a href="#bb0075" class="usa-link" aria-describedby="bb0075">[15]</a>, obtained from Dr. William S. B. Yeung, University of Hong Kong (China), were maintained in DMEM supplemented with 10% FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin. Short tandem repeat analysis performed for 10 markers verified a human female derivation, and all experiments were conducted within 10 passages from the starting stock culture. A PCR detection kit (Applied Biological Materials Inc., Richmond, BC) was used to test for mycoplasma.</p>
<p id="p0040">OE-BRCA1 cells were generated by stable transfection with a wild-type <em>BRCA1</em> expression construct generated by ligating <em>BRCA1</em> cDNA from pcBRCA1-385 (Addgene, Cambridge, MA) into pcDNA3.1H<sup>+</sup> (Invitrogen). OE-Mock cells were transfected in parallel with empty pcDNA3.1H<sup>+</sup>. Stable transfectants were selected using 80 μg/ml Hygromycin B (Invitrogen).</p>
<p id="p0045">2-Amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-(4-piperidinyl)-3-pyridinecarbonitrile (ACHP) (Tocris, Minneapolis, MN) was dissolved in DMSO. Cells were treated with 1 to 25 μM in culture medium for 48 hours. Recombinant human IFN-β (R&amp;D, Minneapolis, MN) was reconstituted in water. Cells were treated with 1000 U/ml culture medium.</p></section><section id="s0030"><h3 class="pmc_sec_title">Ovarian Cancer Cell Lines</h3>
<p id="p0050">SKOV3, ES-2, and HEY ovarian cancer cell lines were grown in RPMI-1640 culture medium supplemented with 5% FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin. UWB1.289 and UWB1.289 +BRCA1 ovarian cancer cells were grown in a 1:1 ratio of RPMI-1640 with mammary epithelial growth medium (ATCC, Manassas, VA). Medium for UWB1.289 +BRCA1 was further supplemented with G418. All cell lines were verified by STR analysis and tested for mycoplasma as described.</p></section><section id="s0035"><h3 class="pmc_sec_title">Periovulatory FF Treatment</h3>
<p id="p0055">FF was obtained from the leading follicle from 14 consenting patients undergoing oocyte retrieval as part of their <em>in vitro</em> fertilization treatment at Mount Sinai Hospital Fertility Center. The FF samples were subjected to cytokine profiling, which was previously reported <a href="#bb0080" class="usa-link" aria-describedby="bb0080">[16]</a>, and was pooled and stored at −80°C. Once FTE cultures reached confluency (2-3 weeks), culture medium in the upper Transwell chamber was replaced with 100 μl filter-sterilized FF for 24 hours followed by replacement with fresh culture medium. Paired baseline cultures were treated in parallel, except culture medium was used instead of FF. The lower chamber contained culture medium alone for all cultures. See <a href="#f0005" class="usa-link">Figure 1</a> for treatment schematic. Exposure of FTE cells to undiluted FF increases rather than decreases cell number <a href="#bb0085" class="usa-link" aria-describedby="bb0085">[17]</a> (<a href="#f0040" class="usa-link">Supplementary Figure S1</a>), indicating that this treatment was not toxic to cells.</p>
<figure class="fig xbox font-sm" id="f0005" title="Figure 1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6030391_gr1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/6030391/88975206ffb9/gr1.jpg" loading="lazy" height="705" width="652" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic showing the treatment paradigm. Dissociated fallopian tube epithelial cells were seeded into the upper chamber of 24-well Transwells coated with collagen IV and grown to confluence <strong>(</strong>A). Follicular fluid (FF) was added to the upper chamber and was replaced with culture medium after 24 hours (B<strong>)</strong>. Cells were harvested 24 hours after FF addition (F24) or 24 hours after replacing FF with culture medium (FC). Parallel cultures from each patient were treated similarly except that culture medium was used instead of FF (C24 and C48).</p></figcaption></figure><figure class="fig xbox font-sm" id="f0040" title="Supplementary Figure S1"><h4 class="obj_head">Supplementary Figure S1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/6030391/4216e933c843/gr8.jpg" loading="lazy" height="782" width="643" alt="Supplementary Figure S1"></p>
<div class="p text-right font-secondary"><a href="figure/f0040/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Cell viability is not compromised by exposure to follicular fluid. Oviductal cells grown on collagen IV were treated with undiluted follicular fluid or culture medium for 24 hours prior to assessment of cell number by MTT reduction assay. Bars represent mean±SEM. <em>P</em>&lt;.05 as determined by Mann-Whitney <em>U</em> test.</p></figcaption></figure></section><section id="s0040"><h3 class="pmc_sec_title">Gene Expression Profiling and Analysis</h3>
<p id="p0065">RNA was extracted from primary FTE cultures using TRIzol (Invitrogen), further purified using an RNeasy MiniElute cleanup kit (Qiagen, Toronto, Canada), and quantified by NanoDrop spectrophotometry. All samples had a minimum RNA integrity value of 8.0 (Agilent bioanalyzer system). Whole genome transcriptome profiling was performed at the Princess Margaret Genomics Centre. RNA (200 ng) was labeled using Illumina TotalPrep-96 RNA amplification kit (Thermo Fisher Scientific, Burlington, Canada), and 750 ng of resulting cDNA was hybridized onto Illumina Human HT-12 v4.0 Beadchip Arrays. The beadchips were washed and stained per Illumina protocol and scanned on an iScan (Illumina) scanner. Gene expression profiling data are available at NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo, accession number <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE98699" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE98699</a>).</p>
<p id="p0070">Microarray data were converted to log2 and quantile median-normalized using Genespring v12.1 software. Samples were run in two balanced batches due to the interval in collecting patient derived material; therefore, a further batch effect normalization was performed using CombatR <a href="#bb0090" class="usa-link" aria-describedby="bb0090">[18]</a>. Unsupervised hierarchical clustering using average linkage rules and Pearson-centered metrics was performed to assess the overall degree of gene expression similarity among samples. All probes were filtered prior to analysis to remove probes showing no signal across all three sample groups (80% of samples in either group having expression in the 20th to 100th percentile of measured signal values). A one-way ANOVA with a TUKEY HSD using Benjamini-Hochberg false discovery rate (FDR) for each comparison was used to identify probes whose mean expression was different between genotypes at each time point.</p>
<p id="p0075">Gene Ontology (GO) analysis was performed on genes significantly different with a 1.5-fold change cutoff between mt<em>BRCA1</em> or mt<em>BRCA2</em> and control samples at the three time points using an FDR &lt;0.3. GSEA was performed between patient groups at the three time points using GSEA software version 2.2.2 and predefined gene sets from the Molecular Signatures Database (MSigDB v5.0). Analysis between patient groups at the three time points involved 1000 permutations using the signal2noise metric. Gene sets with an FDR &lt;0.25 were identified and interactions between gene sets were visualized with Cytoscape software <a href="#bb0095" class="usa-link" aria-describedby="bb0095">[19]</a>.</p></section><section id="s0045"><h3 class="pmc_sec_title">Quantitative Real-Time RT-PCR (RT-qPCR)</h3>
<p id="p0080">RNA was extracted from OE-E6/E7 cells with an RNeasy Plus Universal Mini Kit (Qiagen), and transcript levels for <em>IL8, TNF, HRAS, ISG15, HERC5</em>, <em>USP18</em> in OE-Mock and OE-BRCA1 cells were measured by RT-qPCR using primers shown in <a href="#ec0005" class="usa-link">Supplementary Table S1</a>. RNA was reverse transcribed using Superscript III and random hexamers (Invitrogen). qPCR was performed using an ABI PRISM 7900HT sequence detection system (Invitrogen) with SYBR Green PCR Master Mix (Invitrogen) and analyzed using the ΔCCT method. Target gene C<sub>T</sub> were normalized to the geometric mean of three housekeeping genes, <em>GAPDH</em>, <em>YWHAZ</em>, and <em>B2M</em>, using standard curves. Data are expressed as mean±SEM.</p></section><section id="s0050"><h3 class="pmc_sec_title">Western Blot Analysis</h3>
<p id="p0090">Cellular proteins were extracted using RIPA lysis buffer (50 mM HEPES, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate) containing protease and phosphatase inhibitors (Roche Diagnostics) and quantified using BCA Protein Assay Kit (Thermo Fisher Scientific). Protein extracts were resolved by SDS-PAGE, transferred to PVDF membranes, and immunoblotted with anti-BRCA1 (1:500; sc-6954, Santa Cruz Biotechnology, Dallas, TX), anti-ISG15 (1:2000, a gift from Dr. Arthur Haas, Louisiana State University) <a href="#bb0100" class="usa-link" aria-describedby="bb0100">[20]</a>, anti-EGFR (1:1000, #2232), anti-pERK1/2 (1:2000, #9101), anti-ERK1/2 (1:2000, #4696), anti-USP18 (1:1000, #4813) (Cell Signaling Technology, Danvers, MA), anti-tubulin (1:3000, #T6199, Sigma), or anti-HSP90 (1:5000, #610418, BD Transduction Laboratories, Mississauga, Canada) antibodies. Immunoblots were then incubated with horseradish peroxidase–conjugated goat anti-rabbit (1:1000, sc-2004, Santa Cruz Biotechnology) or horse anti-mouse antibodies (1:1000, #7076, Cell Signaling Technology). Immunoreactive bands were visualized by enhanced chemiluminescence (Santa Cruz Biotechnology) and quantified using ImageJ software.</p></section><section id="s0055"><h3 class="pmc_sec_title">Statistical Analysis</h3>
<p id="p0095">RT-qPCR and Western blot data were analyzed by one-sample <em>t</em> test, one-way ANOVA followed by a Student-Neuman-Keuls (SNK) <em>post hoc</em> test, or two-way ANOVA (Prism 5). Comparisons were considered statistically significant at <em>P</em>&lt;.05.</p></section></section><section id="s0060"><h2 class="pmc_sec_title">Results</h2>
<section id="s0065"><h3 class="pmc_sec_title">mt<em>BRCA</em> Status and FF Exposure Alter Gene Expression Profiles</h3>
<p id="p0100">Primary FTE cell cultures derived from mt<em>BRCA1</em> or mt<em>BRCA2</em> carriers or control patients were grown on collagen IV–coated tissue culture Transwells to simulate <em>in vivo</em> FTE structure <a href="#bb0070" class="usa-link" aria-describedby="bb0070">[14]</a>. Periovulatory human FF was added to the upper chamber for 24 hours to simulate transient apical FTE ovulatory exposure <em>in vivo</em>. Genome-wide gene expression profiles were obtained 24 hours after FF addition (<em>t</em>=F24, acute response) and 24 hours after its replacement with culture medium (<em>t</em>=FC, recovery). Paired baseline (<em>t</em>=C24 and C48) cultures were treated in parallel, except that culture medium was used instead of FF (<a href="#f0005" class="usa-link">Figure 1</a>). Since analysis indicated no differences in gene expression between baseline cultures collected at 24 and 48 hours, only baseline data obtained at 24 hours (C24) were included in further analysis.</p>
<p id="p0105">Unsupervised hierarchical clustering of all 72 culture samples (24 patients × 3 time points) based upon overall gene expression resulted in all three time point samples (C24, F24, FC) from each patient clustering most closely together for 20 of the 24 patients (<a href="#f0010" class="usa-link">Figure 2</a><em>A</em>). While this pattern largely reflects patient variation, an impact of mt<em>BRCA</em> status was indicated. The 72 samples partitioned into 3 main clusters, with mt<em>BRCA1</em> samples dominating one cluster (Group 1A; 67% of mt<em>BRCA1</em>, 33% of mt<em>BRCA2</em>, and 4% control). A second and smaller cluster (Group 1B) contained no mt<em>BRCA1</em>, 25% of mt<em>BRCA2</em>, and 12.5% of control patient samples, whereas the third and largest cluster was dominated by control patient samples (Group 2; 83% of control, 33% of mt<em>BRCA1</em>, and 42% of mt<em>BRCA2</em>). Samples did not partition based upon FF exposure, indicating that mt<em>BRCA</em> status had a greater impact on overall gene expression than FF.</p>
<figure class="fig xbox font-sm" id="f0010" title="Figure 2"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6030391_gr2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/6030391/f009359d8bd0/gr2.jpg" loading="lazy" height="783" width="743" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f0010/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Hierarchical clustering of FTE samples based on gene expression profiles indicates an impact of BRCA1 and BRCA2 mutation status and FF exposure. <strong>(</strong>A) Dendrogram resulting from unsupervised hierarchical clustering of all culture samples based upon expression of all filtered gene probesets. (B<strong>)</strong> Hierarchical clustering of all culture samples based upon expression of 4218 gene probesets identified as significantly different by one-way ANOVA. mt<em>BRCA1</em> samples are coded in red, mt<em>BRCA2</em> samples are coded in blue, and control patient culture samples are coded in green. Sample identification numbers correspond to patient numbers shown in <a href="#t0005" class="usa-link">Table 1</a>.</p></figcaption></figure><p id="p0110">One-way analysis of variance identified 4218 probesets with differential expression between all 9 groups (3 genotypes × 3 timepoints). Clustering of samples based upon these genes revealed three principal groupings, with mt<em>BRCA1</em> samples largely partitioning separately (Group 1) from control patient samples (Group 2B), and mt<em>BRCA2</em> samples distributed evenly within the groupings (<a href="#f0010" class="usa-link">Figure 2</a><em>B</em>). While this pattern further indicates that mutation status has the greatest impact on gene expression, an impact of FF exposure was also evident, as 83% of F24 samples partitioned away from their matched baseline sample. Moreover, a subgroup of F24 samples from all three patient categories clustered together in Group 2A (3 control, 4 mt<em>BRCA1</em>, 5 mt<em>BRCA2</em>).</p></section><section id="s0070"><h3 class="pmc_sec_title">Differentially Expressed Genes Based Upon mt<em>BRCA</em> Status Are Affected by FF Exposure</h3>
<p id="p0115">The overlap in genes differentially expressed based on mt<em>BRCA</em> status at baseline (C24) and after FF exposure (F24 and FC) is shown in <a href="#f0015" class="usa-link">Figure 3</a>. A greater number of probesets were differentially expressed between mt<em>BRCA1</em> versus control patient samples at all time points, as compared to mt<em>BRCA2</em> versus controls. At baseline, 831 probesets were differentially expressed in mt<em>BRCA1</em> samples, and 460 probesets were differentially expressed in mt<em>BRCA2</em> samples, as compared to control patient samples. With acute FF exposure (F24), the number of differentially expressed probesets decreased (615 for mt<em>BRCA1</em> and 111 for mt<em>BRCA2</em>), and this number increased upon recovery from FF exposure (FC) to 1198 for mt<em>BRCA1</em> and 337 for mt<em>BRCA2</em>. Approximately half of the genes differentially expressed in mt<em>BRCA2</em> samples versus control patient samples were also differentially expressed in mt<em>BRCA1</em> samples versus control patient samples (<a href="#f0015" class="usa-link">Figure 3</a>).</p>
<figure class="fig xbox font-sm" id="f0015" title="Figure 3"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6030391_gr3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/6030391/696c91973af0/gr3.jpg" loading="lazy" height="1495" width="739" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/f0015/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>mt<em>BRCA1</em> samples have a greater number of significantly different genes than mt<em>BRCA2</em> samples relative to control FTE at all time points. Overlap of statistically significant differentially expressed gene probesets in mt<em>BRCA1</em> and mt<em>BRCA2</em> samples relative to control patient samples is shown (A) at baseline (C24), (B) after 24hours of FF exposure (F24), and (C) after 24 hours of recovery following FF exposure (FC). Numbers provided are the number of probesets significantly different based upon one-way ANOVA (<em>P</em>&lt;.05). The number of genes with increased expression in BRCA mutants versus control is in the left column, and that with decreased expression in BRCA mutants versus control is in the right column.</p></figcaption></figure><p id="p0120">At FC, there were 44% more probesets differentially expressed between mt<em>BRCA1</em> and control patients than at baseline (1198 vs 831) (<a href="#f0015" class="usa-link">Figure 3</a>), whereas the number of differentially expressed genes in mt<em>BRCA2</em> samples was decreased by 27% (337 vs 460). Moreover, no more than 50% of gene probesets identified as differentially expressed at FC overlapped with either C24 or F24 for mt<em>BRCA1</em> or mt<em>BRCA2</em> samples (<a href="#f0045" class="usa-link">Supplementary Figure S2</a>). This suggests a delayed differential response to FF exposure based on mt<em>BRCA</em> status.</p>
<figure class="fig xbox font-sm" id="f0045" title="Supplementary Figure S2"><h4 class="obj_head">Supplementary Figure S2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6030391_gr9.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/6030391/6d92bbd8df95/gr9.jpg" loading="lazy" height="1197" width="746" alt="Supplementary Figure S2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f0045/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The greatest number of differentially expressed genes relative to control patient samples occurs in mtBRCA1 samples after recovery from follicular fluid exposure (FC). Overlap of statistically significant upregulated (A) or downregulated (B) gene probesets at the three time points in mtBRCA1 or mtBRCA2 samples versus control samples. The number of probesets significantly different based upon one-way ANOVA (<em>P</em>&lt;.05) is indicated.</p></figcaption></figure></section><section id="s0075"><h3 class="pmc_sec_title">mt<em>BRCA1</em> Status Impacts Immune and EGFR Signaling Pathway-Associated Genes</h3>
<p id="p0130">To derive a functional profile of differentially expressed genes at each time point, GO analyses were performed on genes significantly different with a 1.5-fold change cutoff between mt<em>BRCA1</em> or mt<em>BRCA2</em> and control samples. At baseline, genes increased and decreased in mt<em>BRCA1</em> samples associated with 17 and 20 GO terms, respectively (<a href="#ec0010" class="usa-link">Supplementary Table S2</a>). No GO terms associated with genes increased at F24 in mt<em>BRCA1</em>, whereas 7 GO terms associated with decreased genes. At FC, 7 GO terms associated with genes increased in mt<em>BRCA1</em>, and 21 GO terms associated with decreased genes.</p>
<p id="p0140">GO terms identified at all three time points were primarily associated with inflammation and immune system: altogether, 61.4% (27 of 44) of the significant GO terms for mt<em>BRCA1</em> samples were related to the immune system. This suggests that most gene expression changes due to mt<em>BRCA1</em> status alone and to FF exposure involve alterations in immune response or cytokine signaling. Additionally, GO terms relating to proliferation, apoptosis, and cell-cell junction were associated with genes increased in mt<em>BRCA1</em> at baseline. New GO terms emerging at FC included response to virus, innate immune response, and activation of immune response (<a href="#ec0010" class="usa-link">Supplementary Table S2</a>). In contrast, no GO terms associated with mt<em>BRCA2</em> differentially expressed genes either at baseline or FC. At F24, five GO terms were associated with decreased genes in mt<em>BRCA2</em> samples that were related to immune system response and function (<a href="#ec0015" class="usa-link">Supplementary Table S3</a>).</p>
<p id="p0150">As opposed to GO analysis, GSEA is a multivariate tool that takes into account all changes in gene expression to identify multiple pathway members that collectively could amount to a larger impact on particular cell functions. GSEA was performed between all mt<em>BRCA</em> status groups at baseline, F24, and FC. Only comparisons between mt<em>BRCA1</em> versus control patients provided genesets with an FDR &lt;0.25. A total of 246 genesets were upregulated in mt<em>BRCA1</em> versus control at baseline, while no genesets attained significance as downregulated. Many of these upregulated genesets are involved in inflammation, DNA damage, and growth pathways (<a href="#ec0020" class="usa-link">Supplementary Table S4</a>). Visualization of enriched geneset networks using Cytoscape revealed two large clusters: NFκB-related and EGFR-related pathways (<a href="#f0020" class="usa-link">Figure 4</a><em>A</em>). At F24, the only geneset with an FDR &lt;0.25 for mt<em>BRCA1</em> versus control was “Reactome pyruvate metabolism,” which was decreased in mt<em>BRCA1</em> samples.</p>
<figure class="fig xbox font-sm" id="f0020" title="Figure 4"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6030391_gr4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/6030391/db287cf4b249/gr4.jpg" loading="lazy" height="998" width="743" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/f0020/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>GSEA of gene expression profiles from mt<em>BRCA1</em> samples compared to control patient samples reveals three major gene clusters. <strong>(</strong>A) Cytoscape visualization of gene networks increased in mt<em>BRCA1</em> samples versus control patient samples at baseline (C24) showing two main clusters indicating altered NFκB and EGFR signaling. (B) Cytoscape visualization of gene networks increased in mt<em>BRCA1</em> samples versus control patient samples after 24 hours of recovery from FF exposure (FC) showing one main cluster of significant gene sets in mt<em>BRCA1</em>, which reflect altered interferon responsive genes. The size of the node reflects the number of genes within the geneset. Red nodes represent increased expression of the genes within the geneset in mt<em>BRCA1</em> versus control. Edge thickness reflects the number of genes that overlap between connected genesets. All GSEAs were performed using an FDR &lt;0.25.</p></figcaption></figure><p id="p0160">Αt FC, 182 genesets were associated with upregulated genes in mt<em>BRCA1</em> relative to control patient samples (<a href="#ec0025" class="usa-link">Supplementary Table S5</a>). Visualization revealed a large cluster of linked genesets involved with interferon signaling (<a href="#f0020" class="usa-link">Figure 4</a><em>B</em>). Genes forming the leading-edge subset within genesets represent those that contribute most to the enrichment score and have the largest fold-change in expression. The leading-edge gene subset of the top 20 genesets between mt<em>BRCA1</em> and control at FC, based upon the normalized enrichment score, is shown in <a href="#t0010" class="usa-link">Table 2</a>. Among these, <em>ISG15</em> and some of its key interacting partners involved in ISGylation (<em>HERC5</em>, <em>HERC6</em> and <em>USP18</em>) were upregulated in mt<em>BRCA1</em> versus control samples. In fact, <em>ISG15</em> expression was 4.5-fold higher in mt<em>BRCA1</em> versus control samples and appears in 14 of the top 20 genesets at FC. Moreover, <em>ISG15</em> was upregulated 3.4-fold at baseline in mt<em>BRCA1</em> versus control samples.</p>
<section class="tw xbox font-sm" id="t0010"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Significantly Upregulated Genes from the Leading Edge Subset of the Top 20 Gene Sets from the GSEA Comparing mt<em>BRCA1</em> and Control after Recovery from Follicular Fluid Exposure (FC)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1"><em>Gene Symbol</em></th>
<th colspan="1" rowspan="1"><em>Fold Change</em></th>
<th colspan="1" rowspan="1"><em># of Gene Sets Within Top 20</em></th>
<th colspan="1" rowspan="1"><em>Gene Symbol</em></th>
<th colspan="1" rowspan="1"><em>Fold Change</em></th>
<th colspan="1" rowspan="1"><em># of Gene Sets Within Top 20</em></th>
</tr></thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">IFIT1</td>
<td align="center" colspan="1" rowspan="1">6.38</td>
<td colspan="1" rowspan="1">13</td>
<td colspan="1" rowspan="1">FAM46A</td>
<td align="center" colspan="1" rowspan="1">1.86</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">OAS2</td>
<td align="center" colspan="1" rowspan="1">4.95</td>
<td colspan="1" rowspan="1">10</td>
<td colspan="1" rowspan="1">USP18</td>
<td align="center" colspan="1" rowspan="1">1.84</td>
<td colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td colspan="1" rowspan="1">ISG15</td>
<td align="center" colspan="1" rowspan="1">4.50</td>
<td colspan="1" rowspan="1">14</td>
<td colspan="1" rowspan="1">PLAUR</td>
<td align="center" colspan="1" rowspan="1">1.80</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">IFIT3</td>
<td align="center" colspan="1" rowspan="1">3.69</td>
<td colspan="1" rowspan="1">12</td>
<td colspan="1" rowspan="1">SP110</td>
<td align="center" colspan="1" rowspan="1">1.78</td>
<td colspan="1" rowspan="1">5</td>
</tr>
<tr>
<td colspan="1" rowspan="1">MX1</td>
<td align="center" colspan="1" rowspan="1">3.62</td>
<td colspan="1" rowspan="1">13</td>
<td colspan="1" rowspan="1">IFIH1</td>
<td align="center" colspan="1" rowspan="1">1.78</td>
<td colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CXCL10</td>
<td align="center" colspan="1" rowspan="1">3.41</td>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">DDX58</td>
<td align="center" colspan="1" rowspan="1">1.77</td>
<td colspan="1" rowspan="1">7</td>
</tr>
<tr>
<td colspan="1" rowspan="1">IFI44L</td>
<td align="center" colspan="1" rowspan="1">3.30</td>
<td colspan="1" rowspan="1">7</td>
<td colspan="1" rowspan="1">ITGB8</td>
<td align="center" colspan="1" rowspan="1">1.75</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">IRF7</td>
<td align="center" colspan="1" rowspan="1">3.10</td>
<td colspan="1" rowspan="1">12</td>
<td colspan="1" rowspan="1">DDX60</td>
<td align="center" colspan="1" rowspan="1">1.69</td>
<td colspan="1" rowspan="1">7</td>
</tr>
<tr>
<td colspan="1" rowspan="1">MX2</td>
<td align="center" colspan="1" rowspan="1">2.98</td>
<td colspan="1" rowspan="1">7</td>
<td colspan="1" rowspan="1">PAFAH1B3</td>
<td align="center" colspan="1" rowspan="1">1.63</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">RSAD2</td>
<td align="center" colspan="1" rowspan="1">2.97</td>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">EIF2AK2</td>
<td align="center" colspan="1" rowspan="1">1.62</td>
<td colspan="1" rowspan="1">5</td>
</tr>
<tr>
<td colspan="1" rowspan="1">OAS3</td>
<td align="center" colspan="1" rowspan="1">2.95</td>
<td colspan="1" rowspan="1">8</td>
<td colspan="1" rowspan="1">PARP12</td>
<td align="center" colspan="1" rowspan="1">1.61</td>
<td colspan="1" rowspan="1">5</td>
</tr>
<tr>
<td colspan="1" rowspan="1">OAS1</td>
<td align="center" colspan="1" rowspan="1">2.91</td>
<td colspan="1" rowspan="1">10</td>
<td colspan="1" rowspan="1">TSPAN1</td>
<td align="center" colspan="1" rowspan="1">1.60</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">IFI44</td>
<td align="center" colspan="1" rowspan="1">2.90</td>
<td colspan="1" rowspan="1">8</td>
<td colspan="1" rowspan="1">TAP1</td>
<td align="center" colspan="1" rowspan="1">1.58</td>
<td colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td colspan="1" rowspan="1">HERC6</td>
<td align="center" colspan="1" rowspan="1">2.83</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">LAMP3</td>
<td align="center" colspan="1" rowspan="1">1.54</td>
<td colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">EPSTI1</td>
<td align="center" colspan="1" rowspan="1">2.78</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">ARTN</td>
<td align="center" colspan="1" rowspan="1">1.48</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">HS3ST1</td>
<td align="center" colspan="1" rowspan="1">2.72</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">PARP14</td>
<td align="center" colspan="1" rowspan="1">1.46</td>
<td colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td colspan="1" rowspan="1">HERC5</td>
<td align="center" colspan="1" rowspan="1">2.35</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">ATP6V1F</td>
<td align="center" colspan="1" rowspan="1">1.45</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">OASL</td>
<td align="center" colspan="1" rowspan="1">2.29</td>
<td colspan="1" rowspan="1">10</td>
<td colspan="1" rowspan="1">YWHAB</td>
<td align="center" colspan="1" rowspan="1">1.45</td>
<td colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">HLA-C</td>
<td align="center" colspan="1" rowspan="1">2.29</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">PARP10</td>
<td align="center" colspan="1" rowspan="1">1.44</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">SAMD9L</td>
<td align="center" colspan="1" rowspan="1">2.27</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">CMPK2</td>
<td align="center" colspan="1" rowspan="1">1.43</td>
<td colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">IFIT2</td>
<td align="center" colspan="1" rowspan="1">2.26</td>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">IRF3</td>
<td align="center" colspan="1" rowspan="1">1.37</td>
<td colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">IFI35</td>
<td align="center" colspan="1" rowspan="1">2.21</td>
<td colspan="1" rowspan="1">11</td>
<td colspan="1" rowspan="1">ZBP1</td>
<td align="center" colspan="1" rowspan="1">1.33</td>
<td colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td colspan="1" rowspan="1">XAF1</td>
<td align="center" colspan="1" rowspan="1">2.15</td>
<td colspan="1" rowspan="1">8</td>
<td colspan="1" rowspan="1">IFIT5</td>
<td align="center" colspan="1" rowspan="1">1.30</td>
<td colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td colspan="1" rowspan="1">PRIC285</td>
<td align="center" colspan="1" rowspan="1">2.10</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">RIPK3</td>
<td align="center" colspan="1" rowspan="1">1.30</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">PARP9</td>
<td align="center" colspan="1" rowspan="1">2.07</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">DHX58</td>
<td align="center" colspan="1" rowspan="1">1.29</td>
<td colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">STAT1</td>
<td align="center" colspan="1" rowspan="1">2.06</td>
<td colspan="1" rowspan="1">9</td>
<td colspan="1" rowspan="1">NAGK</td>
<td align="center" colspan="1" rowspan="1">1.28</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">DDX60L</td>
<td align="center" colspan="1" rowspan="1">1.98</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">RTEL1</td>
<td align="center" colspan="1" rowspan="1">1.26</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">SAMD9</td>
<td align="center" colspan="1" rowspan="1">1.96</td>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">HRAS</td>
<td align="center" colspan="1" rowspan="1">1.11</td>
<td colspan="1" rowspan="1">1</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t0010/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="s0080"><h3 class="pmc_sec_title">Altering BRCA1 Levels Replicates Key Differences in Gene Expression</h3>
<p id="p0170">OE-E6/E7 immortalized human FTE cells were used to address whether changes in gene expression reflect BRCA1 levels as opposed to differential programming of the primary FTE cells <em>in vivo</em>. OE-E6/E7 cells express low levels of BRCA1 relative to HEY, ES2, and SKOV3 ovarian cancer cell lines (<a href="#f0025" class="usa-link">Figure 5</a><em>A</em>). Therefore, OE-E6/E7 cells were stably transfected with wild-type <em>BRCA1</em> (OE-BRCA1) or transfected with empty expression vector (OE-Mock), resulting in cells expressing high and low BRCA1 levels, respectively (<a href="#f0025" class="usa-link">Figure 5</a><em>A</em>). <em>TNFα</em>, <em>IL8</em>, <em>ISG15</em>, and <em>HRAS</em> were found to have increased expression in mt<em>BRCA1</em> samples at baseline and were selected for investigation. Consistent with our primary FTE gene expression profiles, <em>TNFα, IL8,</em> and <em>ISG15</em> transcript levels were suppressed by increased BRCA1 levels in OE-E6/E7 cells (<a href="#f0025" class="usa-link">Figure 5</a>, <em>B</em>-<em>D</em>), whereas increased BRCA1 did not alter <em>HRAS</em> transcript levels (<a href="#f0025" class="usa-link">Figure 5</a><em>E</em>).</p>
<figure class="fig xbox font-sm" id="f0025" title="Figure 5"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6030391_gr5.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/6030391/78176b36c61e/gr5.jpg" loading="lazy" height="1276" width="652" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/f0025/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Increased BRCA1 expression inhibits expression of NFκB target genes and alters the impact of FF exposure on expression of ISG15 and its interacting partners. (A) Left: Representative Western blot showing BRCA1 protein levels in OE-E6/E7 cells compared to ovarian cancer cell lines. UWB1.289 and UWB1.289+BRCA1 cells were used as a negative and positive control respectively. Right: Representative Western blot and comparison of BRCA1 levels in OE-Mock and OE-BRCA1 cells. Levels of HSP90 are shown as a loading control. Bars represent the mean ± SEM of three independent experiments relative to levels measured in OE-BRCA1 cells. *<em>P</em>=.0075, one-sample <em>t</em> test. (B-E) Comparison of TNFα (B), IL8 (C), ISG15 (D), and HRAS (E) transcript levels in OE-Mock and OE-BRCA1 cells as determined by RT-qPCR. Bars represent the mean ± SEM of three independent experiments relative to levels measured in OE-Mock cells. *<em>P</em>&lt;.05, one-sample <em>t</em> test. (F-H) Comparison of ISG15 (F), HERC5 (G), and USP18 (H<strong>)</strong> transcript levels in OE-Mock and OE-BRCA1 at baseline (C24), after 24 hours of FF exposure (F24), and 24 hours after recovery from FF exposure (FC). Bars represent the mean ± SEM of three (for HERC5 and USP18) or four (for ISG15) independent experiments relative to levels measured in OE-Mock cells at C24. Bars with different letters are statistically different from one another as determined by one-way ANOVA followed by SNK <em>post hoc</em> test.</p></figcaption></figure><p id="p0175">GSEA also indicated that FF treatment of primary FTE cultures transiently suppressed interferon-induced gene expression that was otherwise elevated in mt<em>BRCA1</em> samples at other time points. These genes included multiple regulators of the ISG15 protein modification pathway, including <em>HERC5</em> and <em>USP18</em>. To determine whether these differences could be due to differential BRCA1 levels, OE-Mock and OE-BRCA1 cells were treated with FF in a manner identical to the primary FTE cultures. At baseline and FC, levels of <em>ISG15, HERC5</em>, and <em>USP18</em> transcripts were significantly greater in OE-Mock compared to OE-BRCA1 cells (<a href="#f0025" class="usa-link">Figure 5</a>, <em>F</em>-<em>H</em>), indicating that high levels of BRCA1 suppress their expression. Treatment of OE-Mock cells with FF (F24) suppressed levels of all three transcripts to those measured in OE-BRCA1 cells at baseline.</p>
<p id="p0180">The impact of BRCA1 expression on USP18 and conjugated and free ISG15 protein levels in OE-E6/E7 cells was investigated. Since expression of these genes is activated by type I interferon, protein levels were examined 24 hours after IFNβ or vehicle treatment. In vehicle-treated cells, increased BRCA1 decreased both free ISG15 (<a href="#f0030" class="usa-link">Figure 6</a>, <em>A</em> and <em>B</em>) and USP18 (<a href="#f0030" class="usa-link">Figure 6</a>, <em>D</em> and <em>E</em>), which is consistent with our findings on transcript levels. As expected, similar levels of both proteins in OE-Mock and OE-BRCA1 cells were measured after IFNβ treatment (<a href="#f0030" class="usa-link">Figure 6</a>, <em>B</em> and <em>F</em>). Conjugated ISG15 levels were also increased in OE-Mock relative to OE-BRCA1 cells, and this difference persisted with IFNβ treatment (<a href="#f0030" class="usa-link">Figure 6</a><em>C</em>).</p>
<figure class="fig xbox font-sm" id="f0030" title="Figure 6"><h4 class="obj_head">Figure 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6030391_gr6.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/6030391/41aee6a12480/gr6.jpg" loading="lazy" height="1202" width="658" alt="Figure 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/f0030/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Increased BRCA1 expression inhibits ISGylation and decreases ISG15, USP18, and EGFR protein levels. (A) Representative Western blot showing free and conjugated ISG15 levels in OE-Mock and OE-BRCA1 cells in the presence and absence of 24-hour treatment with 1000 U/ml IFNβ. Levels of HSP90 are shown as a loading control. LE=long exposure; SE=short exposure. (B and C) Comparison of free ISG15 (B) and ISG15 conjugates (C) in OE-Mock and OE-BRCA1 cells in the presence or absence of IFNβ treatment. Bars represent the mean ± SEM of six independent experiments relative to levels measured in vehicle-treated OE-Mock cells. *<em>P</em>&lt;.05; **<em>P</em>&lt;.01; ***<em>P</em>&lt;.001, <em>t</em> test. (D) Representative Western blot showing USP18 levels in OE-Mock and OE-BRCA1 cells in the presence and absence of 24-hour treatment with 1000 U/ml IFNβ. (E and F) Comparison of USP18 levels on OE-Mock and OE-BRCA1 cells in the absence (E) or presence (F) of IFNβ treatment. Bars represent the mean ± SEM of three independent experiments relative to levels measured in OE-Mock cells. Levels of USP18 following IFNβ treatment were determined on short exposure blots. *<em>P</em>&lt;.001, one-sample <em>t</em> test. (G) Representative Western blot showing levels of EGFR in OE-Mock and OE-BRCA1 cells. (H) Comparison of EGFR levels normalized to HSP90. Bars represent the mean ± SEM of four independent experiments relative to levels measured in OE-Mock cells. *<em>P</em>&lt;.02, one-sample <em>t</em> test.</p></figcaption></figure><p id="p0185">Although EGFR mRNA was not increased in mt<em>BRCA1</em> primary FTE cultures, GSEA indicated upregulation of EGFR signaling associated with lower levels of functional BRCA1. Consistent with this inverse relationship, increased BRCA1 expression in OE-E6/E7 cells decreased EGFR protein levels (<a href="#f0030" class="usa-link">Figure 6</a><em>G</em> and <em>H</em>).</p></section><section id="s0085"><h3 class="pmc_sec_title">Increased NFκB Signaling in Cells with Low BRCA1 Levels Increases ISG15, EGFR, and pERK1/2</h3>
<p id="p0190">To investigate whether elevations in ISG15 and EGFR due to decreased BRCA1 levels are mediated through NFκB signaling, OE-Mock and OE-BRCA1 cells were treated with increasing doses of the IKKα/β inhibitor ACHP. Consistent with our findings above, free and conjugated ISG15 (<a href="#f0035" class="usa-link">Figure 7</a>, <em>A</em>-<em>C</em>) and EGFR (<a href="#f0035" class="usa-link">Figure 7</a>, <em>D</em> and <em>E</em>) levels were increased in OE-Mock cells relative to OE-BRCA1 cells. pERK1/2 levels, a downstream EGFR mediator, were also increased in OE-Mock cells (<a href="#f0035" class="usa-link">Figure 7</a>, <em>F</em>-<em>H</em>). ACHP treatment decreased both free and conjugated ISG15 in OE-Mock cells to levels comparable to those in vehicle-treated OE-BRCA1 cells, whereas ACHP treatment did not alter ISG15 levels in OE-BRCA1 cells. Similarly, high (10 and 25 μM) ACHP decreased EGFR protein levels in OE-Mock but not OE-BRCA1 cells. In contrast, pERK1/2 levels were reduced at high doses of ACHP similarly in both OE-Mock and OE-BRCA1 cells. This suggests that elevated ISG15, EGFR, and ERK1/2 activation levels observed in low BRCA1-expressing cells are due to increased NFκB signaling.</p>
<figure class="fig xbox font-sm" id="f0035" title="Figure 7"><h4 class="obj_head">Figure 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6030391_gr7.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/6030391/196cf51f3066/gr7.jpg" loading="lazy" height="1197" width="754" alt="Figure 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/f0035/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Increased NFκB activity in BRCA1-deficient cells leads to increased ISG15 and may contribute to increased EGFR signaling. (A) Representative Western blot showing levels of free and conjugated ISG15 in OE-Mock and OE-BRCA1 cells following inhibition of NFκB signaling by increasing doses of ACHP for 48 hours. Levels of HSP90 are shown as a loading control. LE=long exposure; SE=short exposure. (B and C) Comparison of free (B) and conjugated ISG15 (C) levels normalized to HSP90. Bars represent the mean ± SEM of four independent experiments relative to levels measured in vehicle-treated OE-Mock cells. Two-way ANOVA indicated a significant effect of BRCA1 expression (<em>P</em>&lt;.0001), ACHP treatment (<em>P</em>&lt;.0001), and interaction (<em>P</em>&lt;.0001, free; <em>P</em>&lt;.002, conjugated). The effect of ACHP treatment was analyzed separately for OE-Mock and for OE-BRCA1 cells by one-way ANOVA followed by SNK <em>post hoc</em> test. Bars with different letters within each cell subline are statistically different from one another. (D) Representative Western blot showing levels of EGFR in OE-Mock and OE-BRCA1 cells following ACHP treatment. (E) Comparison of EGFR levels normalized to HSP90 in four independent experiments. Levels are relative to vehicle-treated OE-Mock cells. Two-way ANOVA indicated a significant effect of BRCA1 expression (<em>P</em>&lt;.002) and ACHP treatment (<em>P</em>&lt;.0001), but not interaction. The effect of ACHP treatment was analyzed separately for OE-Mock and for OEBRCA1 cells by one-way ANOVA followed by SNK <em>post hoc</em> test. (F) Representative Western blot showing levels of pERK1/2 in OE-Mock and OE-BRCA1 cells following ACHP treatment. (G and H) Comparison of pERK1 (G) and pERK2 (H) levels normalized to total ERK1 or total ERK2 levels in four independent experiments. Levels are relative to vehicle-treated OE-Mock cells. Two-way ANOVA indicated a significant effect of BRCA1 expression (<em>P</em>&lt;.0001) and ACHP treatment (<em>P</em>&lt;.002, pERK1; <em>P</em>&lt;.0002, pERK2), but no interaction. The effect of ACHP treatment was analyzed separately for OE-Mock and for OE-BRCA1 cells by one-way ANOVA followed by SNK <em>post hoc</em> test. (I) Schematic model for the impact of BRCA1 expression on suppression of inflammatory signaling and ISGylation. ISGylation targets multiple proteins including the EGFR and several members of the downstream MAPK signaling cascade.</p></figcaption></figure></section></section><section id="s0090"><h2 class="pmc_sec_title">Discussion</h2>
<p id="p0195">This study demonstrates that FTE cells from mt<em>BRCA1</em> carriers have a gene expression profile that is distinct from that of FTE from control patients. Even in the absence of FF exposure, mt<em>BRCA1</em> samples displayed molecular profiles indicative of increased inflammatory and EGFR signaling. Moreover, following recovery from FF exposure, an increased expression of type I interferon-responsive genes, including multiple members of the ISGylation protein modification pathway, was apparent in mt<em>BRCA1</em> samples.</p>
<p id="p0200">Numerous genes were also differentially expressed in mt<em>BRCA2</em> samples compared to control patient samples. However, GSEA failed to identify statistically significant genesets. It is interesting to note that the top ranking genesets in mt<em>BRCA2</em> versus control samples were similar to those significantly elevated in mt<em>BRCA1</em> versus control samples, particularly after recovery from FF exposure. These were characterized by elevated interferon target genes (<a href="#ec0030" class="usa-link">Supplementary Table S6</a>, <a href="#ec0035" class="usa-link">Supplementary Table S7</a>). Previous studies have shown increased interferon target gene expression in <em>BRCA2</em>-null colorectal carcinoma cells <a href="#bb0105" class="usa-link" aria-describedby="bb0105">[21]</a> and that BRCA2 binds the transcriptional repressor EMSY to suppress interferon gene expression <a href="#bb0110" class="usa-link" aria-describedby="bb0110">[22]</a>. Further studies are required to investigate the impact of <em>BRCA2</em> mutations on interferon target gene expression and inflammatory signaling.</p>
<p id="p0210">Chronic inflammatory signaling, which is mediated by NFκB, is associated with precipitating events in carcinogenesis and is activated in nearly all cancers <a href="#bb0115" class="usa-link" aria-describedby="bb0115">[23]</a>. Key NFκB target genes, including <em>TNFα</em>, <em>IL8</em>, and <em>ISG15,</em> were increased in mt<em>BRCA1</em> FTE compared to that derived from control patients. Expression of BRCA1 in OE-E6/E7 cells decreased the levels of these transcripts, indicating that this is a direct result of decreased functional BRCA1. TNFα and IL8 promote leukocyte recruitment, and TNFα is a potent activator of further NFκB signaling. Thus, increased expression of these cytokines would likely increase local inflammatory signaling <em>in vivo</em>. An increase in IL8 expression following FF exposure in non–BRCA1-deficient bovine and human oviductal cells was shown by us and others <a href="#bb0080" class="usa-link" aria-describedby="bb0080">[16]</a>, <a href="#bb0085" class="usa-link" aria-describedby="bb0085">[17]</a>. Notably, <em>BRCA1</em>-mutated luteal phase FTE grouping with HGSOC in our previous study showed increased <em>IL8</em> expression, in addition to other monocyte/neutrophil chemokines <a href="#bb0060" class="usa-link" aria-describedby="bb0060">[12]</a>.</p>
<p id="p0215">We previously demonstrated that decreasing BRCA1 expression in ES2 ovarian and A549 lung cancer cells enhanced NFκB signaling <a href="#bb0065" class="usa-link" aria-describedby="bb0065">[13]</a>, but the precise mechanism involved is not clear. Sau et al. <a href="#bb0120" class="usa-link" aria-describedby="bb0120">[24]</a> similarly found increased NFκB signaling in BRCA1-deficient mammary gland progenitor cells, which they attributed to the DNA damage response. However, BRCA1 binds RelA/p65 and p50 and may act as a co-activator to promote canonical NFκB signaling <a href="#bb0125" class="usa-link" aria-describedby="bb0125">[25]</a>; thus, further studies are required to define the precise mechanisms by which BRCA1 deficiency leads to increased NFκB signaling.</p>
<p id="p0220">An inverse relationship between BRCA1 and EGFR has been identified in both breast and ovarian cancer <a href="#bb0130" class="usa-link" aria-describedby="bb0130">[26]</a>, <a href="#bb0135" class="usa-link" aria-describedby="bb0135">[27]</a>. This is consistent with our finding of increased EGFR target gene expression in mt<em>BRCA1</em> samples and a decrease in EGFR levels in OE-E6/E7 cells expressing increased wild-type BRCA1 levels. Inhibition of IKKα/β by ACHP reduced EGFR protein expression in both OE-Mock and OE-BRCA1 cells, indicating that EGFR signaling is downstream of NFκB. Since EGFR also activates NFκB signaling <a href="#bb0140" class="usa-link" aria-describedby="bb0140">[28]</a>, this could lead to a positive feed-forward cycle between EGFR and NFκB in BRCA1-deficient cells.</p>
<p id="p0225">Cross-talk between NFκB and EGFR signaling has been previously demonstrated by others. NFκB regulated KIAA1199/CEMIP was shown to increase EGFR signaling by reducing EGFR lysosome-dependent degradation in cervical and breast cancer cells <a href="#bb0145" class="usa-link" aria-describedby="bb0145">[29]</a>. Also, knockdown of IKKα and IKKβ suppressed EGFR signaling in head and neck cancer cells <a href="#bb0150" class="usa-link" aria-describedby="bb0150">[30]</a>. EGFR has also been shown to activate NFκB signaling either directly or indirectly through JAK/STAT signaling, leading to a positive feed-forward cycle between EGFR and NFκB <a href="#bb0140" class="usa-link" aria-describedby="bb0140">[28]</a>, <a href="#bb0155" class="usa-link" aria-describedby="bb0155">[31]</a>, <a href="#bb0160" class="usa-link" aria-describedby="bb0160">[32]</a>, <a href="#bb0165" class="usa-link" aria-describedby="bb0165">[33]</a>. Elevation of EGFR signaling pathways is involved in cell survival and growth. While activating mutations in downstream EGFR targets such as <em>RAS</em> and <em>ERK</em> are typically associated with low-grade serous ovarian carcinoma, EGFR amplification and overexpression in HGSOC have been reported <a href="#bb0170" class="usa-link" aria-describedby="bb0170">[34]</a>.</p>
<p id="p0230">Previous studies have indicated increased expression of type I interferon target genes in <em>BRCA1-</em> and <em>BRCA2</em>-deficient cells relative to controls in multiple cell types, including breast and HGSOC cells <a href="#bb0105" class="usa-link" aria-describedby="bb0105">[21]</a>, <a href="#bb0175" class="usa-link" aria-describedby="bb0175">[35]</a>; however, this increase did not fully emerge in our nonmalignant primary FTE cell cultures until after FF exposure. Increased <em>ISG15</em> transcripts were identified in mt<em>BRCA1</em> compared to control samples at both baseline and after recovery from FF exposure. <em>ISG15</em> expression is increased in many epithelial cancers <a href="#bb0180" class="usa-link" aria-describedby="bb0180">[36]</a>, <a href="#bb0185" class="usa-link" aria-describedby="bb0185">[37]</a>, <a href="#bb0190" class="usa-link" aria-describedby="bb0190">[38]</a> and contributes to RAS-induced oncogenic transformation of breast epithelial cells <a href="#bb0195" class="usa-link" aria-describedby="bb0195">[39]</a>.</p>
<p id="p0235">ISG15 functions in protein modification and as a mature free protein. While free ISG15 is found intracellularly, it is also secreted and acts upon lymphocytes to induce release of IFNγ and possibly other cytokines <a href="#bb0200" class="usa-link" aria-describedby="bb0200">[40]</a>. Secreted ISG15 was shown to suppress tumor growth, increase natural killer cell tumor infiltration, and enhance cell surface MHC class I expression in breast tumors <a href="#bb0205" class="usa-link" aria-describedby="bb0205">[41]</a>. Thus, free ISG15 may have a different impact on cancer progression than increased ISGylation. BRCA1 expression in OE-E6/E7 cells decreased both free ISG15 and ISGylated protein levels. This suggests that BRCA1 deficiency directly results in increased <em>ISG15</em> expression and demonstrates a functional impact of the altered transcript levels. Several ISG15 E3 ligases have been identified that determine substrate specificity for ISGylation. Among these, HERC5, which was upregulated in OE-Mock versus OE-BRCA1 cells and in mt<em>BRCA1</em> versus control samples after FF recovery, is the most common and has a wide range of target proteins <a href="#bb0210" class="usa-link" aria-describedby="bb0210">[42]</a>.</p>
<p id="p0240">ISGylation has been implicated in cancer development and progression. Desai et al. <a href="#bb0215" class="usa-link" aria-describedby="bb0215">[43]</a> demonstrated that ISGylation disrupts F-actin architecture and formation of focal adhesions, and promotes migration in breast cancer cells. Induction of ISGylation in mice exacerbates intestinal inflammation, increases ROS, and promotes generation of colitis-associated colon cancer <a href="#bb0220" class="usa-link" aria-describedby="bb0220">[44]</a>. ISG15 protein expression is increased in relapsed HGSOCs compared to primary tumors <a href="#bb0225" class="usa-link" aria-describedby="bb0225">[45]</a>. As well, 20% of ovarian cancer cases express an “interferon-related” gene signature that includes ISG15 <a href="#bb0230" class="usa-link" aria-describedby="bb0230">[46]</a>. Over 150 ISGylated proteins have been identified <a href="#bb0235" class="usa-link" aria-describedby="bb0235">[47]</a>; however, the impact of ISGylation on function has only been investigated for a limited number of targets.</p>
<p id="p0245">ISG15 expression is upregulated by TNFα <a href="#bb0240" class="usa-link" aria-describedby="bb0240">[48]</a> and has dual effects on NFκB signaling <a href="#bb0245" class="usa-link" aria-describedby="bb0245">[49]</a>, <a href="#bb0250" class="usa-link" aria-describedby="bb0250">[50]</a>. We demonstrated that blocking NFκB activation decreased ISG15 expression and overall ISGylation in OE-Mock cells to levels measured in OE-BRCA1 cells, indicating that BRCA1 deficiency increases ISG15 levels through increased NFκB signaling. ERK1 has been identified as an ISGylation target <a href="#bb0255" class="usa-link" aria-describedby="bb0255">[51]</a>, and we found increased ERK1/2 activation associated with decreased BRCA1 expression. Further studies are required to determine if ISGylation is involved in the impact of BRCA1 deficiency on ERK1/2 activation as inhibitors to this protein modification pathway are currently unavailable.</p>
<p id="p0250">ISGylation is reversible through the deconjugating activity of USP18 <a href="#bb0260" class="usa-link" aria-describedby="bb0260">[52]</a>, <a href="#bb0265" class="usa-link" aria-describedby="bb0265">[53]</a>. <em>USP18</em> transcripts were not increased in mt<em>BRCA1</em> samples at baseline and emerged as significantly elevated only after FF exposure, when <em>HERC5</em> transcripts were also elevated. Increased BRCA1 levels in OE-E6/E7 cells decreased <em>ISG15, HERC5</em>, and <em>USP18</em> transcripts; however, unlike the primary cultures, this impact on <em>HERC5</em> and <em>USP18</em> was detected at baseline. FF exposure transiently suppressed transcript levels of all three genes in OE-Mock cells to levels similar to those measured in OE-BRCA1 cells, which were unaffected by FF. The variation in overall gene expression between patients could have prevented the interferon gene expression signal reaching statistical significance at baseline in the primary cultures. Alternatively, expression of <em>ISG15</em> interacting partners may vary at baseline but has a concerted response to FF exposure and recovery. It is interesting to note that increased USP18 expression did not prevent the increase in ISGylated protein levels. However, USP18 has independent direct effects on tumor growth and survival and enhances EGFR signaling by decreasing miR-7 expression, which targets EGFR <a href="#bb0270" class="usa-link" aria-describedby="bb0270">[54]</a>. Thus, USP18 may contribute to increased EGFR signaling.</p>
<p id="p0255">While we had expected the combination of FF and <em>BRCA1</em> mutation would globally increase proinflammatory signaling, FF exposure appeared to transiently suppress several inflammatory genes in mt<em>BRCA1</em> cells to the level of controls. Steroid hormones, which are found at high levels in FF, have been shown to decrease NFκB signaling <a href="#bb0275" class="usa-link" aria-describedby="bb0275">[55]</a>, <a href="#bb0280" class="usa-link" aria-describedby="bb0280">[56]</a>, <a href="#bb0285" class="usa-link" aria-describedby="bb0285">[57]</a>. As well, androgens decrease expression of <em>ISG15</em> and its interacting partners <a href="#bb0190" class="usa-link" aria-describedby="bb0190">[38]</a>. Exposure to these hormones in FF may transiently reduce the baseline elevation in inflammatory signaling in mt<em>BRCA1</em> cells to the levels of controls by eliminating their relative increase in NFκB activity.</p>
<p id="p0260">As summarized in <a href="#f0035" class="usa-link">Figure 7</a><em>I</em>, the present study highlights an increase in ISG15 and ISGylation resulting from BRCA1 deficiency and FF exposure. This increase appears to be mediated through increased NFκB signaling due to low levels of functional BRCA1. ISGylation targets multiple proteins, including proteins involved in EGFR and MAPK-ERK1/2 signaling, and has been linked to cancer initiation through increased inflammatory signaling <a href="#bb0220" class="usa-link" aria-describedby="bb0220">[44]</a>. Although not tested, increased ISGylation of EGFR-MAPK-ERK1/2 cascade members might contribute to increased pERK1/2 levels associated with decreased BRCA1. It remains to be determined if blocking ISGylation in BRCA1-deficient FTE results in decreased proinflammatory and EGFR signaling and whether this might mitigate the risk for malignant transformation.</p>
<p id="p0265">The following are the supplementary data related to this article.</p>
<section class="sm xbox font-sm" id="ec0005"><div class="caption p">
<span>Supplementary Table S1</span><p>List of Primers Used for RT-qPCR</p>
</div>
<div class="media p" title="Supplementary Table S1"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc1.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc1.docx</a><sup> (66.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="ec0010"><div class="caption p">
<span>Supplementary Table S2</span><p>GO Analyses for Genes Significantly Different in <em>BRCA1</em> Mutation Carriers Versus Control Patients at the Three Different Time Points</p>
</div>
<div class="media p" title="Supplementary Table S2"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc2.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc2.docx</a><sup> (92.8KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="ec0015"><div class="caption p">
<span>Supplementary Table S3</span><p>GO Analyses for Genes Significantly Different in <em>BRCA2</em> Mutation Carriers Versus Control Patients at the Three Different Time Points</p>
</div>
<div class="media p" title="Supplementary Table S3"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc3.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc3.docx</a><sup> (30.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="ec0020"><div class="caption p">
<span>Supplementary Table S4</span><p>Significant Gene Sets Altered in mt<em>BRCA1</em> Versus Control at C24 Determined by GSEA</p>
</div>
<div class="media p" title="Supplementary Table S4"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc4.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc4.docx</a><sup> (142.2KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="ec0025"><div class="caption p">
<span>Supplementary Table S5</span><p>Significant Gene Sets Altered in mt<em>BRCA1</em> Versus Control at FC Determined by GSEA</p>
</div>
<div class="media p" title="Supplementary Table S5"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc5.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc5.docx</a><sup> (137.7KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="ec0030"><div class="caption p">
<span>Supplementary Table S6</span><p>Top Gene sets Altered in mt<em>BRCA2</em> Versus Control at C24 Determined by GSEA</p>
</div>
<div class="media p" title="Supplementary Table S6"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc6.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc6.docx</a><sup> (76.7KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="ec0035"><div class="caption p">
<span>Supplementary Table S7</span><p>Top Gene Sets Altered in mt<em>BRCA2</em> Versus Control at FC Determined by GSEA</p>
</div>
<div class="media p" title="Supplementary Table S7"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc7.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc7.docx</a><sup> (16.3KB, docx) </sup>
</div></div></section></section><section id="ac0005" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We thank Natalie Stickle for help with data analyses.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="d31e920">
<sup>1</sup><p class="display-inline" id="np0010">Funding: This work was supported by the Canadian Institute of Health Research (grant number MOP106679, 2017). J. H. was supported by a Kristi Piia Callum Memorial Fellowship in Ovarian Cancer.</p>
</div>
<div class="fn p" id="d31e934">
<sup>2</sup><p class="display-inline" id="np0015">Declarations of Interest: None.</p>
</div>
</div></section><section id="bi0005" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="bi0005_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="bb0005">
<span class="label">1.</span><cite>Crum CP, Drapkin R, Miron A, Ince TA, Muto M, Kindelberger DW, Lee Y. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol. 2007;19:3–9. doi: 10.1097/GCO.0b013e328011a21f.</cite> [<a href="https://doi.org/10.1097/GCO.0b013e328011a21f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17218844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Opin%20Obstet%20Gynecol&amp;title=The%20distal%20fallopian%20tube:%20a%20new%20model%20for%20pelvic%20serous%20carcinogenesis&amp;author=CP%20Crum&amp;author=R%20Drapkin&amp;author=A%20Miron&amp;author=TA%20Ince&amp;author=M%20Muto&amp;volume=19&amp;publication_year=2007&amp;pages=3-9&amp;pmid=17218844&amp;doi=10.1097/GCO.0b013e328011a21f&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0010">
<span class="label">2.</span><cite>Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329–1333. doi: 10.1200/JCO.2006.09.1066.</cite> [<a href="https://doi.org/10.1200/JCO.2006.09.1066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2267287/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17416853/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Meta-analysis%20of%20BRCA1%20and%20BRCA2%20penetrance&amp;author=S%20Chen&amp;author=G%20Parmigiani&amp;volume=25&amp;publication_year=2007&amp;pages=1329-1333&amp;pmid=17416853&amp;doi=10.1200/JCO.2006.09.1066&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0015">
<span class="label">3.</span><cite>King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302:643–646. doi: 10.1126/science.1088759.</cite> [<a href="https://doi.org/10.1126/science.1088759" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14576434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Breast%20and%20ovarian%20cancer%20risks%20due%20to%20inherited%20mutations%20in%20BRCA1%20and%20BRCA2&amp;author=MC%20King&amp;author=JH%20Marks&amp;author=JB%20Mandell&amp;volume=302&amp;publication_year=2003&amp;pages=643-646&amp;pmid=14576434&amp;doi=10.1126/science.1088759&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0020">
<span class="label">4.</span><cite>Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105:812–822. doi: 10.1093/jnci/djt095.</cite> [<a href="https://doi.org/10.1093/jnci/djt095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23628597/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Natl%20Cancer%20Inst&amp;title=Cancer%20risks%20for%20BRCA1%20and%20BRCA2%20mutation%20carriers:%20results%20from%20prospective%20analysis%20of%20EMBRACE&amp;author=N%20Mavaddat&amp;author=S%20Peock&amp;author=D%20Frost&amp;author=S%20Ellis&amp;author=R%20Platte&amp;volume=105&amp;publication_year=2013&amp;pages=812-822&amp;pmid=23628597&amp;doi=10.1093/jnci/djt095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0025">
<span class="label">5.</span><cite>Boyd J, Sonoda Y, Federici MG, Bogomolniy F, Rhei E, Maresco DL, Saigo PE, Almadrones LA, Barakat RR, Brown CL. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA. 2000;283:2260–2265. doi: 10.1001/jama.283.17.2260.</cite> [<a href="https://doi.org/10.1001/jama.283.17.2260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10807385/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Clinicopathologic%20features%20of%20BRCA-linked%20and%20sporadic%20ovarian%20cancer&amp;author=J%20Boyd&amp;author=Y%20Sonoda&amp;author=MG%20Federici&amp;author=F%20Bogomolniy&amp;author=E%20Rhei&amp;volume=283&amp;publication_year=2000&amp;pages=2260-2265&amp;pmid=10807385&amp;doi=10.1001/jama.283.17.2260&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0030">
<span class="label">6.</span><cite>Havrilesky LJ, Moorman PG, Lowery WJ, Gierisch JM, Coeytaux RR, Urrutia RP, Dinan M, McBroom AJ, Hasselblad V, Sanders GD. Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis. Obstet Gynecol. 2013;122:139–147. doi: 10.1097/AOG.0b013e318291c235.</cite> [<a href="https://doi.org/10.1097/AOG.0b013e318291c235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23743450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Obstet%20Gynecol&amp;title=Oral%20contraceptive%20pills%20as%20primary%20prevention%20for%20ovarian%20cancer:%20a%20systematic%20review%20and%20meta-analysis&amp;author=LJ%20Havrilesky&amp;author=PG%20Moorman&amp;author=WJ%20Lowery&amp;author=JM%20Gierisch&amp;author=RR%20Coeytaux&amp;volume=122&amp;publication_year=2013&amp;pages=139-147&amp;pmid=23743450&amp;doi=10.1097/AOG.0b013e318291c235&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0035">
<span class="label">7.</span><cite>Tung KH, Wilkens LR, AH Wu, McDuffie K, Nomura AM, Kolonel LN, Terada KY, Goodman MT. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. Am J Epidemiol. 2005;161:321–329. doi: 10.1093/aje/kwi046.</cite> [<a href="https://doi.org/10.1093/aje/kwi046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15692075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Epidemiol&amp;title=Effect%20of%20anovulation%20factors%20on%20pre-%20and%20postmenopausal%20ovarian%20cancer%20risk:%20revisiting%20the%20incessant%20ovulation%20hypothesis&amp;author=KH%20Tung&amp;author=LR%20Wilkens&amp;author=Wu%20AH&amp;author=K%20McDuffie&amp;author=AM%20Nomura&amp;volume=161&amp;publication_year=2005&amp;pages=321-329&amp;pmid=15692075&amp;doi=10.1093/aje/kwi046&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0040">
<span class="label">8.</span><cite>McGuire V, Felberg A, Mills M, Ostrow KL, DiCioccio R, John EM, West DW, Whittemore AS. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. Am J Epidemiol. 2004;160:613–618. doi: 10.1093/aje/kwh284.</cite> [<a href="https://doi.org/10.1093/aje/kwh284" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15383404/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Epidemiol&amp;title=Relation%20of%20contraceptive%20and%20reproductive%20history%20to%20ovarian%20cancer%20risk%20in%20carriers%20and%20noncarriers%20of%20BRCA1%20gene%20mutations&amp;author=V%20McGuire&amp;author=A%20Felberg&amp;author=M%20Mills&amp;author=KL%20Ostrow&amp;author=R%20DiCioccio&amp;volume=160&amp;publication_year=2004&amp;pages=613-618&amp;pmid=15383404&amp;doi=10.1093/aje/kwh284&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0045">
<span class="label">9.</span><cite>McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet Oncol. 2007;8:26–34. doi: 10.1016/S1470-2045(06)70983-4.</cite> [<a href="https://doi.org/10.1016/S1470-2045(06)70983-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17196508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Reproductive%20risk%20factors%20for%20ovarian%20cancer%20in%20carriers%20of%20BRCA1%20or%20BRCA2%20mutations:%20a%20case-control%20study&amp;author=JR%20McLaughlin&amp;author=HA%20Risch&amp;author=J%20Lubinski&amp;author=P%20Moller&amp;author=P%20Ghadirian&amp;volume=8&amp;publication_year=2007&amp;pages=26-34&amp;pmid=17196508&amp;doi=10.1016/S1470-2045(06)70983-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0050">
<span class="label">10.</span><cite>Buscher U, Chen FC, Kentenich H, Schmiady H. Cytokines in the follicular fluid of stimulated and non-stimulated human ovaries; is ovulation a suppressed inflammatory reaction? Hum Reprod. 1999;14:162–166. doi: 10.1093/humrep/14.1.162.</cite> [<a href="https://doi.org/10.1093/humrep/14.1.162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10374114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Reprod&amp;title=Cytokines%20in%20the%20follicular%20fluid%20of%20stimulated%20and%20non-stimulated%20human%20ovaries;%20is%20ovulation%20a%20suppressed%20inflammatory%20reaction?&amp;author=U%20Buscher&amp;author=FC%20Chen&amp;author=H%20Kentenich&amp;author=H%20Schmiady&amp;volume=14&amp;publication_year=1999&amp;pages=162-166&amp;pmid=10374114&amp;doi=10.1093/humrep/14.1.162&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0055">
<span class="label">11.</span><cite>Fleming JS, Beaugie CR, Haviv I, Chenevix-Trench G, Tan OL. Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol. 2006;247:4–21. doi: 10.1016/j.mce.2005.09.014.</cite> [<a href="https://doi.org/10.1016/j.mce.2005.09.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16297528/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell%20Endocrinol&amp;title=Incessant%20ovulation,%20inflammation%20and%20epithelial%20ovarian%20carcinogenesis:%20revisiting%20old%20hypotheses&amp;author=JS%20Fleming&amp;author=CR%20Beaugie&amp;author=I%20Haviv&amp;author=G%20Chenevix-Trench&amp;author=OL%20Tan&amp;volume=247&amp;publication_year=2006&amp;pages=4-21&amp;pmid=16297528&amp;doi=10.1016/j.mce.2005.09.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0060">
<span class="label">12.</span><cite>Tone AA, Begley H, Sharma M, Murphy J, Rosen B, Brown TJ, Shaw PA. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma. Clin Cancer Res. 2008;14:4067–4078. doi: 10.1158/1078-0432.CCR-07-4959.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-07-4959" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18593983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Gene%20expression%20profiles%20of%20luteal%20phase%20fallopian%20tube%20epithelium%20from%20BRCA%20mutation%20carriers%20resemble%20high-grade%20serous%20carcinoma&amp;author=AA%20Tone&amp;author=H%20Begley&amp;author=M%20Sharma&amp;author=J%20Murphy&amp;author=B%20Rosen&amp;volume=14&amp;publication_year=2008&amp;pages=4067-4078&amp;pmid=18593983&amp;doi=10.1158/1078-0432.CCR-07-4959&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0065">
<span class="label">13.</span><cite>Tone AA, Virtanen C, Shaw P, Brown TJ. Prolonged postovulatory proinflammatory signaling in the fallopian tube epithelium may be mediated through a BRCA1/DAB2 axis. Clin Cancer Res. 2012;18:4334–4344. doi: 10.1158/1078-0432.CCR-12-0199.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-12-0199" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22753593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Prolonged%20postovulatory%20proinflammatory%20signaling%20in%20the%20fallopian%20tube%20epithelium%20may%20be%20mediated%20through%20a%20BRCA1/DAB2%20axis&amp;author=AA%20Tone&amp;author=C%20Virtanen&amp;author=P%20Shaw&amp;author=TJ%20Brown&amp;volume=18&amp;publication_year=2012&amp;pages=4334-4344&amp;pmid=22753593&amp;doi=10.1158/1078-0432.CCR-12-0199&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0070">
<span class="label">14.</span><cite>Fotheringham S, Levanon K, Drapkin R. Ex vivo culture of primary human fallopian tube epithelial cells. J Vis Exp. 2011;51:2728. doi: 10.3791/2728.</cite> [<a href="https://doi.org/10.3791/2728" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3197121/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21610668/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Vis%20Exp&amp;title=Ex%20vivo%20culture%20of%20primary%20human%20fallopian%20tube%20epithelial%20cells&amp;author=S%20Fotheringham&amp;author=K%20Levanon&amp;author=R%20Drapkin&amp;volume=51&amp;publication_year=2011&amp;pages=2728&amp;pmid=21610668&amp;doi=10.3791/2728&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0075">
<span class="label">15.</span><cite>Lee YL, Lee KF, JS Xu, Wang YL, Tsao SW, Yeung WS. Establishment and characterization of an immortalized human oviductal cell line. Mol Reprod Dev. 2001;59:400–409. doi: 10.1002/mrd.1046.</cite> [<a href="https://doi.org/10.1002/mrd.1046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11468776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Reprod%20Dev&amp;title=Establishment%20and%20characterization%20of%20an%20immortalized%20human%20oviductal%20cell%20line&amp;author=YL%20Lee&amp;author=KF%20Lee&amp;author=Xu%20JS&amp;author=YL%20Wang&amp;author=SW%20Tsao&amp;volume=59&amp;publication_year=2001&amp;pages=400-409&amp;pmid=11468776&amp;doi=10.1002/mrd.1046&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0080">
<span class="label">16.</span><cite>Lau A, Kollara A, St John E, Tone AA, Virtanen C, Greenblatt EM, King WA, Brown TJ. Altered expression of inflammation-associated genes in oviductal cells following follicular fluid exposure: implications for ovarian carcinogenesis. Exp Biol Med (Maywood) 2014;239:24–32. doi: 10.1177/1535370213508216.</cite> [<a href="https://doi.org/10.1177/1535370213508216" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24186266/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Biol%20Med%20(Maywood)&amp;title=Altered%20expression%20of%20inflammation-associated%20genes%20in%20oviductal%20cells%20following%20follicular%20fluid%20exposure:%20implications%20for%20ovarian%20carcinogenesis&amp;author=A%20Lau&amp;author=A%20Kollara&amp;author=E%20St%20John&amp;author=AA%20Tone&amp;author=C%20Virtanen&amp;volume=239&amp;publication_year=2014&amp;pages=24-32&amp;pmid=24186266&amp;doi=10.1177/1535370213508216&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0085">
<span class="label">17.</span><cite>Bahar-Shany K, Brand H, Sapoznik S, Jacob-Hirsch J, Yung Y, Korach J, Perri T, Cohen Y, Hourvitz A, Levanon K. Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma. Gynecol Oncol. 2014;132:322–327. doi: 10.1016/j.ygyno.2013.12.015.</cite> [<a href="https://doi.org/10.1016/j.ygyno.2013.12.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24355484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol%20Oncol&amp;title=Exposure%20of%20fallopian%20tube%20epithelium%20to%20follicular%20fluid%20mimics%20carcinogenic%20changes%20in%20precursor%20lesions%20of%20serous%20papillary%20carcinoma&amp;author=K%20Bahar-Shany&amp;author=H%20Brand&amp;author=S%20Sapoznik&amp;author=J%20Jacob-Hirsch&amp;author=Y%20Yung&amp;volume=132&amp;publication_year=2014&amp;pages=322-327&amp;pmid=24355484&amp;doi=10.1016/j.ygyno.2013.12.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0090">
<span class="label">18.</span><cite>Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118–127. doi: 10.1093/biostatistics/kxj037.</cite> [<a href="https://doi.org/10.1093/biostatistics/kxj037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16632515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biostatistics&amp;title=Adjusting%20batch%20effects%20in%20microarray%20expression%20data%20using%20empirical%20Bayes%20methods&amp;author=WE%20Johnson&amp;author=C%20Li&amp;author=A%20Rabinovic&amp;volume=8&amp;publication_year=2007&amp;pages=118-127&amp;pmid=16632515&amp;doi=10.1093/biostatistics/kxj037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0095">
<span class="label">19.</span><cite>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504. doi: 10.1101/gr.1239303.</cite> [<a href="https://doi.org/10.1101/gr.1239303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC403769/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14597658/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Res&amp;title=Cytoscape:%20a%20software%20environment%20for%20integrated%20models%20of%20biomolecular%20interaction%20networks&amp;author=P%20Shannon&amp;author=A%20Markiel&amp;author=O%20Ozier&amp;author=NS%20Baliga&amp;author=JT%20Wang&amp;volume=13&amp;publication_year=2003&amp;pages=2498-2504&amp;pmid=14597658&amp;doi=10.1101/gr.1239303&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0100">
<span class="label">20.</span><cite>Loeb KR, Haas AL. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem. 1992;267:7806–7813.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1373138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&amp;title=The%20interferon-inducible%2015-kDa%20ubiquitin%20homolog%20conjugates%20to%20intracellular%20proteins&amp;author=KR%20Loeb&amp;author=AL%20Haas&amp;volume=267&amp;publication_year=1992&amp;pages=7806-7813&amp;pmid=1373138&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0105">
<span class="label">21.</span><cite>H Xu, Xian J, Vire E, McKinney S, Wei V, Wong J, Tong R, Kouzarides T, Caldas C, Aparicio S. Up-regulation of the interferon-related genes in BRCA2 knockout epithelial cells. J Pathol. 2014;234:386–397. doi: 10.1002/path.4404.</cite> [<a href="https://doi.org/10.1002/path.4404" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4882165/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25043256/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pathol&amp;title=Up-regulation%20of%20the%20interferon-related%20genes%20in%20BRCA2%20knockout%20epithelial%20cells&amp;author=Xu%20H&amp;author=J%20Xian&amp;author=E%20Vire&amp;author=S%20McKinney&amp;author=V%20Wei&amp;volume=234&amp;publication_year=2014&amp;pages=386-397&amp;pmid=25043256&amp;doi=10.1002/path.4404&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0110">
<span class="label">22.</span><cite>Ezell SA, Polytarchou C, Hatziapostolou M, Guo A, Sanidas I, Bihani T, Comb MJ, Sourvinos G, Tsichlis PN. The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY. Proc Natl Acad Sci U S A. 2012;109:E613–E621. doi: 10.1073/pnas.1115029109.</cite> [<a href="https://doi.org/10.1073/pnas.1115029109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3309773/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22315412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=The%20protein%20kinase%20Akt1%20regulates%20the%20interferon%20response%20through%20phosphorylation%20of%20the%20transcriptional%20repressor%20EMSY&amp;author=SA%20Ezell&amp;author=C%20Polytarchou&amp;author=M%20Hatziapostolou&amp;author=A%20Guo&amp;author=I%20Sanidas&amp;volume=109&amp;publication_year=2012&amp;pages=E613-E621&amp;pmid=22315412&amp;doi=10.1073/pnas.1115029109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0115">
<span class="label">23.</span><cite>Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013;12(86):1–15. doi: 10.1186/1476-4598-12-86.</cite> [<a href="https://doi.org/10.1186/1476-4598-12-86" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3750319/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23915189/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer&amp;title=The%20complexity%20of%20NF-%CE%BAB%20signaling%20in%20inflammation%20and%20cancer&amp;author=B%20Hoesel&amp;author=JA%20Schmid&amp;volume=12&amp;issue=86&amp;publication_year=2013&amp;pages=1-15&amp;pmid=23915189&amp;doi=10.1186/1476-4598-12-86&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0120">
<span class="label">24.</span><cite>Sau A, Lau R, Cabrita MA, Nolan E, Crooks PA, Visvader JE, Pratt MA. Persistent Activation of NF-kappaB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage. Cell Stem Cell. 2016;19:52–65. doi: 10.1016/j.stem.2016.05.003.</cite> [<a href="https://doi.org/10.1016/j.stem.2016.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6850408/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27292187/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Stem%20Cell&amp;title=Persistent%20Activation%20of%20NF-kappaB%20in%20BRCA1-Deficient%20Mammary%20Progenitors%20Drives%20Aberrant%20Proliferation%20and%20Accumulation%20of%20DNA%20Damage&amp;author=A%20Sau&amp;author=R%20Lau&amp;author=MA%20Cabrita&amp;author=E%20Nolan&amp;author=PA%20Crooks&amp;volume=19&amp;publication_year=2016&amp;pages=52-65&amp;pmid=27292187&amp;doi=10.1016/j.stem.2016.05.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0125">
<span class="label">25.</span><cite>Benezra M, Chevallier N, Morrison DJ, MacLachlan TK, El-Deiry WS, Licht JD. BRCA1 augments transcription by the NF-kappaB transcription factor by binding to the Rel domain of the p65/RelA subunit. J Biol Chem. 2003;278:26333–26341. doi: 10.1074/jbc.M303076200.</cite> [<a href="https://doi.org/10.1074/jbc.M303076200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12700228/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&amp;title=BRCA1%20augments%20transcription%20by%20the%20NF-kappaB%20transcription%20factor%20by%20binding%20to%20the%20Rel%20domain%20of%20the%20p65/RelA%20subunit&amp;author=M%20Benezra&amp;author=N%20Chevallier&amp;author=DJ%20Morrison&amp;author=TK%20MacLachlan&amp;author=WS%20El-Deiry&amp;volume=278&amp;publication_year=2003&amp;pages=26333-26341&amp;pmid=12700228&amp;doi=10.1074/jbc.M303076200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0130">
<span class="label">26.</span><cite>LN Burga H Hu, Juvekar A, Tung NM, Troyan SL, Hofstatter EW, Wulf GM. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. Breast Cancer Res. 2011;13:R30. doi: 10.1186/bcr2850.</cite> [<a href="https://doi.org/10.1186/bcr2850" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3219192/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21396117/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res&amp;title=Loss%20of%20BRCA1%20leads%20to%20an%20increase%20in%20epidermal%20growth%20factor%20receptor%20expression%20in%20mammary%20epithelial%20cells,%20and%20epidermal%20growth%20factor%20receptor%20inhibition%20prevents%20estrogen%20receptor-negative%20cancers%20in%20BRCA1-mutant%20mice&amp;author=H%20Hu%20LN%20Burga&amp;author=A%20Juvekar&amp;author=NM%20Tung&amp;author=SL%20Troyan&amp;author=EW%20Hofstatter&amp;volume=13&amp;publication_year=2011&amp;pages=R30&amp;pmid=21396117&amp;doi=10.1186/bcr2850&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0135">
<span class="label">27.</span><cite>Li D, Bi FF, Cao JM, Cao C, Li CY, Yang Q. Effect of BRCA1 on epidermal growth factor receptor in ovarian cancer. J Exp Clin Cancer Res. 2013;32:102. doi: 10.1186/1756-9966-32-102. 6 pp.</cite> [<a href="https://doi.org/10.1186/1756-9966-32-102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4029425/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24321281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Exp%20Clin%20Cancer%20Res&amp;title=Effect%20of%20BRCA1%20on%20epidermal%20growth%20factor%20receptor%20in%20ovarian%20cancer&amp;author=D%20Li&amp;author=FF%20Bi&amp;author=JM%20Cao&amp;author=C%20Cao&amp;author=CY%20Li&amp;volume=32&amp;publication_year=2013&amp;pages=102&amp;pmid=24321281&amp;doi=10.1186/1756-9966-32-102&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0140">
<span class="label">28.</span><cite>De S, Dermawan JK, Stark GR. EGF receptor uses SOS1 to drive constitutive activation of NFkappaB in cancer cells. Proc Natl Acad Sci U S A. 2014;111:11721–11726. doi: 10.1073/pnas.1412390111.</cite> [<a href="https://doi.org/10.1073/pnas.1412390111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4136585/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25071181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=EGF%20receptor%20uses%20SOS1%20to%20drive%20constitutive%20activation%20of%20NFkappaB%20in%20cancer%20cells&amp;author=S%20De&amp;author=JK%20Dermawan&amp;author=GR%20Stark&amp;volume=111&amp;publication_year=2014&amp;pages=11721-11726&amp;pmid=25071181&amp;doi=10.1073/pnas.1412390111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0145">
<span class="label">29.</span><cite>Shostak K, Zhang X, Hubert P, Goktuna SI, Jiang Z, Klevernic I, Hildebrand J, Roncarati P, Hennuy B, Ladang A. NF-kappaB-induced KIAA1199 promotes survival through EGFR signalling. Nat Commun. 2014;5:5232. doi: 10.1038/ncomms6232. 19 pp.</cite> [<a href="https://doi.org/10.1038/ncomms6232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4241993/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25366117/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=NF-kappaB-induced%20KIAA1199%20promotes%20survival%20through%20EGFR%20signalling&amp;author=K%20Shostak&amp;author=X%20Zhang&amp;author=P%20Hubert&amp;author=SI%20Goktuna&amp;author=Z%20Jiang&amp;volume=5&amp;publication_year=2014&amp;pages=5232&amp;pmid=25366117&amp;doi=10.1038/ncomms6232&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0150">
<span class="label">30.</span><cite>Nottingham LK, Yan CH, Yang X, Si H, Coupar J, Bian Y, TF Cheng C, Allen P, Arun D Gius. Aberrant IKKalpha and IKKbeta cooperatively activate NF-kappaB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer. Oncogene. 2014;33:1135–1147. doi: 10.1038/onc.2013.49.</cite> [<a href="https://doi.org/10.1038/onc.2013.49" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3926900/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23455325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Aberrant%20IKKalpha%20and%20IKKbeta%20cooperatively%20activate%20NF-kappaB%20and%20induce%20EGFR/AP1%20signaling%20to%20promote%20survival%20and%20migration%20of%20head%20and%20neck%20cancer&amp;author=LK%20Nottingham&amp;author=CH%20Yan&amp;author=X%20Yang&amp;author=H%20Si&amp;author=J%20Coupar&amp;volume=33&amp;publication_year=2014&amp;pages=1135-1147&amp;pmid=23455325&amp;doi=10.1038/onc.2013.49&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0155">
<span class="label">31.</span><cite>Biswas DK, Cruz AP, Gansberger E, Pardee AB. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci U S A. 2000;97:8542–8547. doi: 10.1073/pnas.97.15.8542.</cite> [<a href="https://doi.org/10.1073/pnas.97.15.8542" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC26984/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10900013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Epidermal%20growth%20factor-induced%20nuclear%20factor%20kappa%20B%20activation:%20A%20major%20pathway%20of%20cell-cycle%20progression%20in%20estrogen-receptor%20negative%20breast%20cancer%20cells&amp;author=DK%20Biswas&amp;author=AP%20Cruz&amp;author=E%20Gansberger&amp;author=AB%20Pardee&amp;volume=97&amp;publication_year=2000&amp;pages=8542-8547&amp;pmid=10900013&amp;doi=10.1073/pnas.97.15.8542&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0160">
<span class="label">32.</span><cite>Le Page C, Koumakpayi IH, Lessard L, Mes-Masson AM, Saad F. EGFR and Her-2 regulate the constitutive activation of NF-kappaB in PC-3 prostate cancer cells. Prostate. 2005;65:130–140. doi: 10.1002/pros.20234.</cite> [<a href="https://doi.org/10.1002/pros.20234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15880609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prostate&amp;title=EGFR%20and%20Her-2%20regulate%20the%20constitutive%20activation%20of%20NF-kappaB%20in%20PC-3%20prostate%20cancer%20cells&amp;author=C%20Le%20Page&amp;author=IH%20Koumakpayi&amp;author=L%20Lessard&amp;author=AM%20Mes-Masson&amp;author=F%20Saad&amp;volume=65&amp;publication_year=2005&amp;pages=130-140&amp;pmid=15880609&amp;doi=10.1002/pros.20234&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0165">
<span class="label">33.</span><cite>Jiang T, Grabiner B, Zhu Y, Jiang C, Li H, You Y, Lang J, Hung MC, Lin X. CARMA3 is crucial for EGFR-Induced activation of NF-kappaB and tumor progression. Cancer Res. 2011;71:2183–2192. doi: 10.1158/0008-5472.CAN-10-3626.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-10-3626" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3059846/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21406399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=CARMA3%20is%20crucial%20for%20EGFR-Induced%20activation%20of%20NF-kappaB%20and%20tumor%20progression&amp;author=T%20Jiang&amp;author=B%20Grabiner&amp;author=Y%20Zhu&amp;author=C%20Jiang&amp;author=H%20Li&amp;volume=71&amp;publication_year=2011&amp;pages=2183-2192&amp;pmid=21406399&amp;doi=10.1158/0008-5472.CAN-10-3626&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0170">
<span class="label">34.</span><cite>Lassus H, Sihto H, Leminen A, Joensuu H, Isola J, Nupponen NN, Butzow R. Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma. J Mol Med (Berl) 2006;84:671–681. doi: 10.1007/s00109-006-0054-4.</cite> [<a href="https://doi.org/10.1007/s00109-006-0054-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16607561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Mol%20Med%20(Berl)&amp;title=Gene%20amplification,%20mutation,%20and%20protein%20expression%20of%20EGFR%20and%20mutations%20of%20ERBB2%20in%20serous%20ovarian%20carcinoma&amp;author=H%20Lassus&amp;author=H%20Sihto&amp;author=A%20Leminen&amp;author=H%20Joensuu&amp;author=J%20Isola&amp;volume=84&amp;publication_year=2006&amp;pages=671-681&amp;pmid=16607561&amp;doi=10.1007/s00109-006-0054-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0175">
<span class="label">35.</span><cite>Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J Natl Cancer Inst. 2002;94:990–1000. doi: 10.1093/jnci/94.13.990.</cite> [<a href="https://doi.org/10.1093/jnci/94.13.990" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12096084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Natl%20Cancer%20Inst&amp;title=Gene%20expression%20profiles%20of%20BRCA1-linked,%20BRCA2-linked,%20and%20sporadic%20ovarian%20cancers&amp;author=AA%20Jazaeri&amp;author=CJ%20Yee&amp;author=C%20Sotiriou&amp;author=KR%20Brantley&amp;author=J%20Boyd&amp;volume=94&amp;publication_year=2002&amp;pages=990-1000&amp;pmid=12096084&amp;doi=10.1093/jnci/94.13.990&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0180">
<span class="label">36.</span><cite>Chi LM, Lee CW, Chang KP, Hao SP, HM Lee Y, Liang C, Hsueh CJ Yu, Lee IN, Chang YJ. Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS. Mol Cell Proteomics. 2009;8:1453–1474. doi: 10.1074/mcp.M800460-MCP200.</cite> [<a href="https://doi.org/10.1074/mcp.M800460-MCP200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2709179/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19297561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell%20Proteomics&amp;title=Enhanced%20interferon%20signaling%20pathway%20in%20oral%20cancer%20revealed%20by%20quantitative%20proteome%20analysis%20of%20microdissected%20specimens%20using%2016O/18O%20labeling%20and%20integrated%20two-dimensional%20LC-ESI-MALDI%20tandem%20MS&amp;author=LM%20Chi&amp;author=CW%20Lee&amp;author=KP%20Chang&amp;author=SP%20Hao&amp;author=Y%20HM%20Lee&amp;volume=8&amp;publication_year=2009&amp;pages=1453-1474&amp;pmid=19297561&amp;doi=10.1074/mcp.M800460-MCP200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0185">
<span class="label">37.</span><cite>Andersen JB, Aaboe M, Borden EC, Goloubeva OG, Hassel BA, Orntoft TF. Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer. Br J Cancer. 2006;94:1465–1471. doi: 10.1038/sj.bjc.6603099.</cite> [<a href="https://doi.org/10.1038/sj.bjc.6603099" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2361278/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16641915/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Cancer&amp;title=Stage-associated%20overexpression%20of%20the%20ubiquitin-like%20protein,%20ISG15,%20in%20bladder%20cancer&amp;author=JB%20Andersen&amp;author=M%20Aaboe&amp;author=EC%20Borden&amp;author=OG%20Goloubeva&amp;author=BA%20Hassel&amp;volume=94&amp;publication_year=2006&amp;pages=1465-1471&amp;pmid=16641915&amp;doi=10.1038/sj.bjc.6603099&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0190">
<span class="label">38.</span><cite>Kiessling A, Hogrefe C, Erb S, Bobach C, Fuessel S, Wessjohann L, Seliger B. Expression, regulation and function of the ISGylation system in prostate cancer. Oncogene. 2009;28:2606–2620. doi: 10.1038/onc.2009.115.</cite> [<a href="https://doi.org/10.1038/onc.2009.115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19430494/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Expression,%20regulation%20and%20function%20of%20the%20ISGylation%20system%20in%20prostate%20cancer&amp;author=A%20Kiessling&amp;author=C%20Hogrefe&amp;author=S%20Erb&amp;author=C%20Bobach&amp;author=S%20Fuessel&amp;volume=28&amp;publication_year=2009&amp;pages=2606-2620&amp;pmid=19430494&amp;doi=10.1038/onc.2009.115&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0195">
<span class="label">39.</span><cite>Tsai YC, Pestka S, Wang LH, Runnels LW, Wan S, Lyu YL, Liu LF. Interferon-beta signaling contributes to Ras transformation. PLoS One. 2011;6 doi: 10.1371/journal.pone.0024291.</cite> [<a href="https://doi.org/10.1371/journal.pone.0024291" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3163666/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21897875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Interferon-beta%20signaling%20contributes%20to%20Ras%20transformation&amp;author=YC%20Tsai&amp;author=S%20Pestka&amp;author=LH%20Wang&amp;author=LW%20Runnels&amp;author=S%20Wan&amp;volume=6&amp;publication_year=2011&amp;pmid=21897875&amp;doi=10.1371/journal.pone.0024291&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0200">
<span class="label">40.</span><cite>Bogunovic D, Boisson-Dupuis S, Casanova JL. ISG15: leading a double life as a secreted molecule. Exp Mol Med. 2013;45:e18. doi: 10.1038/emm.2013.36.</cite> [<a href="https://doi.org/10.1038/emm.2013.36" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3641400/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23579383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Mol%20Med&amp;title=ISG15:%20leading%20a%20double%20life%20as%20a%20secreted%20molecule&amp;author=D%20Bogunovic&amp;author=S%20Boisson-Dupuis&amp;author=JL%20Casanova&amp;volume=45&amp;publication_year=2013&amp;pages=e18&amp;pmid=23579383&amp;doi=10.1038/emm.2013.36&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0205">
<span class="label">41.</span><cite>Burks J, Reed RE, Desai SD. Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective. Oncotarget. 2015;6:7221–7231. doi: 10.18632/oncotarget.3372.</cite> [<a href="https://doi.org/10.18632/oncotarget.3372" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4466680/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25749047/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Free%20ISG15%20triggers%20an%20antitumor%20immune%20response%20against%20breast%20cancer:%20a%20new%20perspective&amp;author=J%20Burks&amp;author=RE%20Reed&amp;author=SD%20Desai&amp;volume=6&amp;publication_year=2015&amp;pages=7221-7231&amp;pmid=25749047&amp;doi=10.18632/oncotarget.3372&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0210">
<span class="label">42.</span><cite>Dastur A, Beaudenon S, Kelley M, Krug RM, Huibregtse JM. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem. 2006;281:4334–4338. doi: 10.1074/jbc.M512830200.</cite> [<a href="https://doi.org/10.1074/jbc.M512830200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16407192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&amp;title=Herc5,%20an%20interferon-induced%20HECT%20E3%20enzyme,%20is%20required%20for%20conjugation%20of%20ISG15%20in%20human%20cells&amp;author=A%20Dastur&amp;author=S%20Beaudenon&amp;author=M%20Kelley&amp;author=RM%20Krug&amp;author=JM%20Huibregtse&amp;volume=281&amp;publication_year=2006&amp;pages=4334-4338&amp;pmid=16407192&amp;doi=10.1074/jbc.M512830200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0215">
<span class="label">43.</span><cite>Desai SD, Reed RE, Burks J, Wood LM, Pullikuth AK, Haas AL, Liu LF, Breslin JW, Meiners S, Sankar S. ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells. Exp Biol Med. 2012;237:38–49. doi: 10.1258/ebm.2011.011236.</cite> [<a href="https://doi.org/10.1258/ebm.2011.011236" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22185919/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Biol%20Med&amp;title=ISG15%20disrupts%20cytoskeletal%20architecture%20and%20promotes%20motility%20in%20human%20breast%20cancer%20cells&amp;author=SD%20Desai&amp;author=RE%20Reed&amp;author=J%20Burks&amp;author=LM%20Wood&amp;author=AK%20Pullikuth&amp;volume=237&amp;publication_year=2012&amp;pages=38-49&amp;pmid=22185919&amp;doi=10.1258/ebm.2011.011236&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0220">
<span class="label">44.</span><cite>Fan JB, Miyauchi-Ishida S, Arimoto K, Liu D, Yan M, Liu CW, Gyorffy B, Zhang DE. Type I IFN induces protein ISGylation to enhance cytokine expression and augments colonic inflammation. Proc Natl Acad Sci U S A. 2015;112:14313–14318. doi: 10.1073/pnas.1505690112.</cite> [<a href="https://doi.org/10.1073/pnas.1505690112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4655505/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26515094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Type%20I%20IFN%20induces%20protein%20ISGylation%20to%20enhance%20cytokine%20expression%20and%20augments%20colonic%20inflammation&amp;author=JB%20Fan&amp;author=S%20Miyauchi-Ishida&amp;author=K%20Arimoto&amp;author=D%20Liu&amp;author=M%20Yan&amp;volume=112&amp;publication_year=2015&amp;pages=14313-14318&amp;pmid=26515094&amp;doi=10.1073/pnas.1505690112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0225">
<span class="label">45.</span><cite>Darb-Esfahani S, Sinn BV, Rudl M, Sehouli J, Braicu I, Dietel M, Denkert C. Interferon-stimulated gene, 15 kDa (ISG15) in ovarian high-grade serous carcinoma: prognostic impact and link to NF-kappaB pathway. Int J Gynecol Pathol. 2014;33:16–22. doi: 10.1097/PGP.0b013e31827b25a2.</cite> [<a href="https://doi.org/10.1097/PGP.0b013e31827b25a2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24300530/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Gynecol%20Pathol&amp;title=Interferon-stimulated%20gene,%2015%20kDa%20(ISG15)%20in%20ovarian%20high-grade%20serous%20carcinoma:%20prognostic%20impact%20and%20link%20to%20NF-kappaB%20pathway&amp;author=S%20Darb-Esfahani&amp;author=BV%20Sinn&amp;author=M%20Rudl&amp;author=J%20Sehouli&amp;author=I%20Braicu&amp;volume=33&amp;publication_year=2014&amp;pages=16-22&amp;pmid=24300530&amp;doi=10.1097/PGP.0b013e31827b25a2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0230">
<span class="label">46.</span><cite>Einav U, Tabach Y, Getz G, Yitzhaky A, Ozbek U, Amariglio N, Izraeli S, Rechavi G, Domany E. Gene expression analysis reveals a strong signature of an interferon-induced pathway in childhood lymphoblastic leukemia as well as in breast and ovarian cancer. Oncogene. 2005;24:6367–6375. doi: 10.1038/sj.onc.1208797.</cite> [<a href="https://doi.org/10.1038/sj.onc.1208797" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16007187/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Gene%20expression%20analysis%20reveals%20a%20strong%20signature%20of%20an%20interferon-induced%20pathway%20in%20childhood%20lymphoblastic%20leukemia%20as%20well%20as%20in%20breast%20and%20ovarian%20cancer&amp;author=U%20Einav&amp;author=Y%20Tabach&amp;author=G%20Getz&amp;author=A%20Yitzhaky&amp;author=U%20Ozbek&amp;volume=24&amp;publication_year=2005&amp;pages=6367-6375&amp;pmid=16007187&amp;doi=10.1038/sj.onc.1208797&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0235">
<span class="label">47.</span><cite>Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A. 2005;102:10200–10205. doi: 10.1073/pnas.0504754102.</cite> [<a href="https://doi.org/10.1073/pnas.0504754102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1177427/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16009940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Human%20ISG15%20conjugation%20targets%20both%20IFN-induced%20and%20constitutively%20expressed%20proteins%20functioning%20in%20diverse%20cellular%20pathways&amp;author=C%20Zhao&amp;author=C%20Denison&amp;author=JM%20Huibregtse&amp;author=S%20Gygi&amp;author=RM%20Krug&amp;volume=102&amp;publication_year=2005&amp;pages=10200-10205&amp;pmid=16009940&amp;doi=10.1073/pnas.0504754102&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0240">
<span class="label">48.</span><cite>Chairatvit K, Wongnoppavich A, Choonate S. Up-regulation of interferon-stimulated gene15 and its conjugates by tumor necrosis factor-alpha via type I interferon-dependent and -independent pathways. Mol Cell Biochem. 2012;368:195–201. doi: 10.1007/s11010-012-1360-5.</cite> [<a href="https://doi.org/10.1007/s11010-012-1360-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22729740/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell%20Biochem&amp;title=Up-regulation%20of%20interferon-stimulated%20gene15%20and%20its%20conjugates%20by%20tumor%20necrosis%20factor-alpha%20via%20type%20I%20interferon-dependent%20and%20-independent%20pathways&amp;author=K%20Chairatvit&amp;author=A%20Wongnoppavich&amp;author=S%20Choonate&amp;volume=368&amp;publication_year=2012&amp;pages=195-201&amp;pmid=22729740&amp;doi=10.1007/s11010-012-1360-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0245">
<span class="label">49.</span><cite>Minakawa M, Sone T, Takeuchi T, Yokosawa H. Regulation of the nuclear factor (NF)-kappaB pathway by ISGylation. Biol Pharm Bull. 2008;31:2223–2227. doi: 10.1248/bpb.31.2223.</cite> [<a href="https://doi.org/10.1248/bpb.31.2223" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19043203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biol%20Pharm%20Bull&amp;title=Regulation%20of%20the%20nuclear%20factor%20(NF)-kappaB%20pathway%20by%20ISGylation&amp;author=M%20Minakawa&amp;author=T%20Sone&amp;author=T%20Takeuchi&amp;author=H%20Yokosawa&amp;volume=31&amp;publication_year=2008&amp;pages=2223-2227&amp;pmid=19043203&amp;doi=10.1248/bpb.31.2223&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0250">
<span class="label">50.</span><cite>Takeuchi T, Kobayashi T, Tamura S, Yokosawa H. Negative regulation of protein phosphatase 2Cbeta by ISG15 conjugation. FEBS Lett. 2006;580:4521–4526. doi: 10.1016/j.febslet.2006.07.032.</cite> [<a href="https://doi.org/10.1016/j.febslet.2006.07.032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16872604/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Lett&amp;title=Negative%20regulation%20of%20protein%20phosphatase%202Cbeta%20by%20ISG15%20conjugation&amp;author=T%20Takeuchi&amp;author=T%20Kobayashi&amp;author=S%20Tamura&amp;author=H%20Yokosawa&amp;volume=580&amp;publication_year=2006&amp;pages=4521-4526&amp;pmid=16872604&amp;doi=10.1016/j.febslet.2006.07.032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0255">
<span class="label">51.</span><cite>Malakhov MP, Kim KI, Malakhova OA, Jacobs BS, Borden EC, Zhang DE. High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J Biol Chem. 2003;278:16608–16613. doi: 10.1074/jbc.M208435200.</cite> [<a href="https://doi.org/10.1074/jbc.M208435200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12582176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&amp;title=High-throughput%20immunoblotting.%20Ubiquitiin-like%20protein%20ISG15%20modifies%20key%20regulators%20of%20signal%20transduction&amp;author=MP%20Malakhov&amp;author=KI%20Kim&amp;author=OA%20Malakhova&amp;author=BS%20Jacobs&amp;author=EC%20Borden&amp;volume=278&amp;publication_year=2003&amp;pages=16608-16613&amp;pmid=12582176&amp;doi=10.1074/jbc.M208435200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0260">
<span class="label">52.</span><cite>Liu LQ, Ilaria R, Jr., Kingsley PD, Iwama A, van Etten RA, Palis J. DE Zhang. A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation. Mol Cell Biol. 1999;19:3029–3038. doi: 10.1128/mcb.19.4.3029.</cite> [<a href="https://doi.org/10.1128/mcb.19.4.3029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC84097/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10082570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell%20Biol&amp;title=DE%20Zhang.%20A%20novel%20ubiquitin-specific%20protease,%20UBP43,%20cloned%20from%20leukemia%20fusion%20protein%20AML1-ETO-expressing%20mice,%20functions%20in%20hematopoietic%20cell%20differentiation&amp;author=LQ%20Liu&amp;author=R%20Ilaria&amp;author=PD%20Kingsley&amp;author=A%20Iwama&amp;author=RA%20van%20Etten&amp;volume=19&amp;publication_year=1999&amp;pages=3029-3038&amp;pmid=10082570&amp;doi=10.1128/mcb.19.4.3029&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0265">
<span class="label">53.</span><cite>Mustachio LM, Lu Y, Kawakami M, Roszik J, Freemantle SJ, Liu X, Dmitrovsky E. Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target. Cancer Res. 2018;78:587–592. doi: 10.1158/0008-5472.CAN-17-1752.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-17-1752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6080720/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29343520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Evidence%20for%20the%20ISG15-Specific%20Deubiquitinase%20USP18%20as%20an%20Antineoplastic%20Target&amp;author=LM%20Mustachio&amp;author=Y%20Lu&amp;author=M%20Kawakami&amp;author=J%20Roszik&amp;author=SJ%20Freemantle&amp;volume=78&amp;publication_year=2018&amp;pages=587-592&amp;pmid=29343520&amp;doi=10.1158/0008-5472.CAN-17-1752&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0270">
<span class="label">54.</span><cite>Honke N, Shaabani N, Zhang DE, Hardt C, Lang KS. Multiple functions of USP18. Cell Death Dis. 2016;7 doi: 10.1038/cddis.2016.326.</cite> [<a href="https://doi.org/10.1038/cddis.2016.326" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5260889/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27809302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=Multiple%20functions%20of%20USP18&amp;author=N%20Honke&amp;author=N%20Shaabani&amp;author=DE%20Zhang&amp;author=C%20Hardt&amp;author=KS%20Lang&amp;volume=7&amp;publication_year=2016&amp;pmid=27809302&amp;doi=10.1038/cddis.2016.326&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0275">
<span class="label">55.</span><cite>He YH, Zhang HN, Zhang GP, Hou N, Xiao Q, Huang Y, Wu JH, Luo MS, Zhang GS, Yi Q. A physiological concentration of glucocorticoid inhibits the pro-inflammatory cytokine-induced proliferation of adult rat cardiac fibroblasts: roles of extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB. Clin Exp Pharmacol Physiol. 2011;38:739–746. doi: 10.1111/j.1440-1681.2011.05581.x.</cite> [<a href="https://doi.org/10.1111/j.1440-1681.2011.05581.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21819443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Exp%20Pharmacol%20Physiol&amp;title=A%20physiological%20concentration%20of%20glucocorticoid%20inhibits%20the%20pro-inflammatory%20cytokine-induced%20proliferation%20of%20adult%20rat%20cardiac%20fibroblasts:%20roles%20of%20extracellular%20signal-regulated%20kinase%201/2%20and%20nuclear%20factor-kappaB&amp;author=YH%20He&amp;author=HN%20Zhang&amp;author=GP%20Zhang&amp;author=N%20Hou&amp;author=Q%20Xiao&amp;volume=38&amp;publication_year=2011&amp;pages=739-746&amp;pmid=21819443&amp;doi=10.1111/j.1440-1681.2011.05581.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0280">
<span class="label">56.</span><cite>Lei B, Mace B, Dawson HN, Warner DS, Laskowitz DT, James ML. Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia. PLoS One. 2014;9 doi: 10.1371/journal.pone.0103969.</cite> [<a href="https://doi.org/10.1371/journal.pone.0103969" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4117574/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25080336/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Anti-inflammatory%20effects%20of%20progesterone%20in%20lipopolysaccharide-stimulated%20BV-2%20microglia&amp;author=B%20Lei&amp;author=B%20Mace&amp;author=HN%20Dawson&amp;author=DS%20Warner&amp;author=DT%20Laskowitz&amp;volume=9&amp;publication_year=2014&amp;pmid=25080336&amp;doi=10.1371/journal.pone.0103969&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bb0285">
<span class="label">57.</span><cite>Xing D, Oparil S, Yu H, Gong K, Feng W, Black J, Chen YF, Nozell S. Estrogen modulates NFkappaB signaling by enhancing IkappaBalpha levels and blocking p65 binding at the promoters of inflammatory genes via estrogen receptor-beta. PLoS One. 2012;7 doi: 10.1371/journal.pone.0036890.</cite> [<a href="https://doi.org/10.1371/journal.pone.0036890" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3378567/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22723832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Estrogen%20modulates%20NFkappaB%20signaling%20by%20enhancing%20IkappaBalpha%20levels%20and%20blocking%20p65%20binding%20at%20the%20promoters%20of%20inflammatory%20genes%20via%20estrogen%20receptor-beta&amp;author=D%20Xing&amp;author=S%20Oparil&amp;author=H%20Yu&amp;author=K%20Gong&amp;author=W%20Feng&amp;volume=7&amp;publication_year=2012&amp;pmid=22723832&amp;doi=10.1371/journal.pone.0036890&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>Supplementary Table S1</span><p>List of Primers Used for RT-qPCR</p>
</div>
<div class="media p" title="Supplementary Table S1"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc1.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc1.docx</a><sup> (66.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>Supplementary Table S2</span><p>GO Analyses for Genes Significantly Different in <em>BRCA1</em> Mutation Carriers Versus Control Patients at the Three Different Time Points</p>
</div>
<div class="media p" title="Supplementary Table S2"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc2.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc2.docx</a><sup> (92.8KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>Supplementary Table S3</span><p>GO Analyses for Genes Significantly Different in <em>BRCA2</em> Mutation Carriers Versus Control Patients at the Three Different Time Points</p>
</div>
<div class="media p" title="Supplementary Table S3"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc3.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc3.docx</a><sup> (30.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p">
<span>Supplementary Table S4</span><p>Significant Gene Sets Altered in mt<em>BRCA1</em> Versus Control at C24 Determined by GSEA</p>
</div>
<div class="media p" title="Supplementary Table S4"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc4.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc4.docx</a><sup> (142.2KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p">
<span>Supplementary Table S5</span><p>Significant Gene Sets Altered in mt<em>BRCA1</em> Versus Control at FC Determined by GSEA</p>
</div>
<div class="media p" title="Supplementary Table S5"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc5.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc5.docx</a><sup> (137.7KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="caption p">
<span>Supplementary Table S6</span><p>Top Gene sets Altered in mt<em>BRCA2</em> Versus Control at C24 Determined by GSEA</p>
</div>
<div class="media p" title="Supplementary Table S6"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc6.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc6.docx</a><sup> (76.7KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material7_reqid_"><div class="caption p">
<span>Supplementary Table S7</span><p>Top Gene Sets Altered in mt<em>BRCA2</em> Versus Control at FC Determined by GSEA</p>
</div>
<div class="media p" title="Supplementary Table S7"><div class="caption">
<a href="/articles/instance/6030391/bin/mmc7.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc7.docx</a><sup> (16.3KB, docx) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Neoplasia (New York, N.Y.) are provided here courtesy of <strong>Neoplasia Press</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1016/j.neo.2018.05.005"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/main.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/6030391/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/6030391/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC6030391%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC6030391/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC6030391/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC6030391/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/29852322/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC6030391/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/29852322/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC6030391/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/6030391/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="cX4lyg014scv8wOzlCp3Q81KUSZ8raSRO7uyk8tzlaGPjCjABBNDngUq1KoluVnm">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
